FURUKOORI NORIO

Profiles

Profiles

• 氏名

  FURUKOORI NORIO

Affiliation

• Department of Psychiatry, Professor

Profile and Settings

Research Experience

• Apr. 2019
• Apr. 2019
• Apr. 2019

Research achievements

Published Papers

Original paper
• 15, 3069-3078, Nov. 2019

  DOI
• 8-Hydroxylation and Glucuronidation of Mirtazapine in Japanese Psychiatric Patients: Significance of the Glucuronidation Pathway of 8-Hydroxy-Mirtazapine., Shinozaki M, Pierce J, Hayashi Y, Watanabe T, Sasaki T, Komahashi-Sasaki H, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Ozeki Y, Shimoda K., Pharmacopsychiatry., 52(5), 237-244, Sep. 2019

  DOI
• Coping behaviors and depressive status in individuals with type 2 diabetes mellitus., Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N., Ann Gen Psychiatry., 18, 11., Jul. 2019

  DOI
• Association between insomnia and personality traits among Japanese patients with type 2 diabetes mellitus., Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Yoshida K, Sugawara N, Yasui-Furukori N, Daimon M., J Diabetes Investig., 10(2), 484-490, Apr. 2019

  DOI
• Personality associated with depressive status in individuals with type 2 diabetes mellitus., Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N., Neuropsychiatr Dis Treat., 15, 1133-1139, Mar. 2019

  DOI
• Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs., Kubo K, Fleischhacker WW, Suzuki T, Yasui-Furukori N, Mimura M, Uchida H., Acta Psychiatr Scand., 139(2), 108-116, Feb. 2019

  DOI
• Higher plasma leptin and lower C-peptide levels are associated with depression: A cross-sectional study., Takekawa D, Kudo T, Saito J, Kimura F, Nikaido Y, Sawada K, Yasui-Furukori N, Hirota K., J Affect Disord. 2019 Jan 15;, 243, 70-74, Jan. 2019

  DOI
• Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan., Sugawara N, Kudo S, Ishioka M, Sato Y, Kubo K, Yasui-Furukori N., Neuropsychiatr Dis Treat., 15, 205-211, Jan. 2019

  DOI
• Early Placebo Improvement Is a Marker for Subsequent Placebo Response in Long-Acting Injectable Antipsychotic Trials for Schizophrenia: Combined Analysis of 4 RCTs., Kumagai F, Suzuki T, Fleischhacker WW, Yasui-Furukori N, Mimura M, Uchida H., J Clin Psychiatry., 80(1), 18m12144, Dec. 2018

  DOI
• Differences in etiological beliefs about schizophrenia among patients, family, and medical staff., Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N., Neuropsychiatr Dis Treat., 15, 137-142, Dec. 2018

  DOI
• Effects of personality on the association between paroxetine plasma concentration and response., Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K., Neuropsychiatr Dis Treat., 14, 3299-3306, Nov. 2018

  DOI
• Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus., Yoshida K, Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Sugawara N, Nakamura K, Daimon M, Yasui-Furukori N., Neuropsychiatr Dis Treat., 14, 1803-1809, Jul. 2018

  DOI
• Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression., Tsuchimine S, Ochi S, Tajiri M, Suzuki Y, Sugawara N, Inoue Y, Yasui-Furukori N., Ther Drug Monit., 40(3), 356-361, Jun. 2018

  DOI
• High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey., Ono S, Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Okamoto K, Sagae T, Someya T., BMC Psychiatry., 18(1), 180, Jun. 2018

  DOI
• Increased levels of CREB in major depressive patients with antidepressant treatment., Tsuchimine S, Sugawara N, Yasui-Furukori N., Psychiatry Res., 263, 296-297, May 2018

  DOI
• Irritable bowel syndrome and quality of life in a community-dwelling population in Japan., Sugawara N, Sato K, Takahashi I, Satake R, Fukuda S, Nakaji S, Yasui-Furukori N., Int J Psychiatry Med., 53(3), 159-170, May 2018

  DOI
• The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients., Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N., Neuropsychiatr Dis Treat., 14, 1319-1327, May 2018

  DOI
• Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation., Tomita T, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K, Yasui-Furukori N., Neuropsychiatr Dis Treat., 14, 505-510, Feb. 2018

  DOI
• Effects of nutritional education on weight change and metabolic abnormalities among patients with schizophrenia in Japan: A randomized controlled trial., Sugawara N, Sagae T, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, Matsuda H, Suzuki Y, Ozeki Y, Okamoto K, Someya T., J Psychiatr Res., 97, 77-83, Feb. 2018

  DOI
• Attitudes toward placebo-controlled clinical trials among depressed patients in Japan., Sugawara N, Ishioka M, Tsuchimine S, Tsuruga K, Sato Y, Tarakita N, Furukori H, Kudo S, Tomita T, Nakagami T, Yasui-Furukori N., J Affect Disord., 225, 313-316, Jan. 2018

  DOI
• The Association Between the Severity and Level of Understanding of Depression Among Patients Treated With Antidepressants: A Survey of 424 Outpatients in Japan., Tomita T, Yasui-Furukori N, Kudo S, Sugawara N, Fujii A, Tsuruga K, Sato Y, Ishioka M, Nakamura K., Clin Neuropharmacol., 41(1), 1-5, Jan. 2018

  DOI
• Delirium in hemodialysis predicts mortality: a single-center, long-term observational study., Yasui-Furukori N, Tarakita N, Uematsu W, Saito H, Nakamura K, Ohyama C, Sugawara N., Neuropsychiatr Dis Treat., 13, 3011-3016, Dec. 2017

  DOI
• Depressive Symptoms and Coping Behaviors among Individuals with Irritable Bowel Syndrome in Japan., Sugawara N, Sato K, Takahashi I, Satake R, Fukuda S, Nakaji S, Yasui-Furukori N., Intern Med. 2017;56(5):493-498., 56(5), 493-498, Oct. 2017

  DOI
• Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan., Sugawara N, Kaneda A, Takahashi I, Nakaji S, Yasui-Furukori N., Neuropsychiatr Dis Treat, 13, 2369-2374, Sep. 2017

  DOI
• Work-family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan., Sugawara N, Danjo K, Furukori H, Sato Y, Tomita T, Fujii A, Nakagami T, Kitaoka K, Yasui-Furukori N., Neuropsychiatr Dis Treat., 13, 779-784, Mar. 2017
• Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV., Tomita T, Yasui-Furukori N, Sugawara N, Ogasawara K, Katagai K, Saito H, Sawada K, Takahashi I, Nakamura K., Neuropsychiatr Dis Treat., 12, 2503-2508, Nov. 2016
• High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey, Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Minami Y, Okamoto K, Sagae T, Someya T, PLoS One, 11(11), e0166429, Nov. 2016

  DOI
• Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis., Nishimura M, Ueda M, Saruwatari J, Nakashima H, Ogusu N, Aoki A, Tsuchimine S, Matsuda K, Iwashita K, Ono T, Oniki K, Shimoda K, Yasui-Furukori N., Pharmacogenet Genomics, 26(9), 403-413, Sep. 2016

  DOI
• The Effect of Yokukansan, a Traditional Herbal Preparation Used for the Behavioral and Psychological Symptoms of Dementia, on the Drug-Metabolizing Enzyme Activities in Healthy Male Volunteers., Soraoka H, Oniki K, Matsuda K, Ono T, Taharazako K, Uchiyashiki Y, Kamihashi R, Kita A, Takashima A, Nakagawa K, Yasui-Furukori N, Kadowaki D, Miyata K, Saruwatari J., Biol Pharm Bull., 39(9), 1468-1474, Sep. 2016

  DOI
• 12, 2293-2298, Sep. 2016

  DOI
• 16, 290, Aug. 2016

  DOI
• 38(4), 483-486, Aug. 2016

  DOI
• 39(3), 135-139, May 2016

  DOI
• 39(3), 125-127, May 2016

  DOI
• 239, 190-195, May 2016

  DOI
• 15, 12., Apr. 2016

  DOI
• 12, 809-815, Apr. 2016

  DOI
• Serum x03C9;-3 and x03C9;-6 Fatty Acids Are Not Associated with Personality Traits in Healthy Japanese Young People., Tsuchimine S, Kaneda A, Yasui-Furukori N., Neuropsychobiology., 73(4), 249-253, Apr. 2016

  DOI
• 171(1-3), 68-73, Mar. 2016

  DOI
• 12, 427-436, Feb. 2016

  DOI
• Relationship between occupational stress and depression among psychiatric nurses in Japan., Yoshizawa K, Sugawara N, Yasui-Furukori N, Danjo K, Furukori H, Sato Y, Tomita T, Fujii A, Nakagam T, Sasaki M, Nakamura K., Arch Environ Occup Health., 71(1), 10-5, Jan. 2016

  DOI
• The gamma-interferon (IFN-γ) gene +874 T>A polymorphism is not associated with personality traits in healthy Japanese subjects., Tsuchimine S, Kaneda A, Yasui-Furukori N., Brain Behav Immun., 51, 268-269, Jan. 2016

  DOI
• High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey., Sugai T, Suzuki Y, Yamazaki M, Shimoda K, Mori T, Ozeki Y, Matsuda H, Sugawara N, Yasui-Furukori N, Minami Y, Okamoto K, Sagae T, Someya T., BMJ Open., 5(12), e008720, Dec. 2015

  DOI
• The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis., Tomita T, Yasui-Furukori N, Sugawara N, Takahashi I, Sawada K, Nakamura K., Neuropsychiatr Dis Treat., 11, 2935-2941, Nov. 2015

  DOI
• Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan., Sugawara N, Ishioka M, Tsuchimine S, Tsuruga K, Sato Y, Furukori H, Kudo S, Tomita T, Nakagami T, Yasui-Furukori N., PLoS One., 10(11), e0143356, Nov. 2015

  DOI
• Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients., Hayashi Y, Watanabe T, Aoki A, Ishiguro S, Ueda M, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K., Pharmacopsychiatry, 48(7), 279-285, Nov. 2015

  DOI
• Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis., Nakashima H, Oniki K, Nishimura M, Ogusu N, Shimomasuda M, Ono T, Matsuda K, Yasui-Furukori N, Nakagawa K, Ishitsu T, Saruwatari J., PLoS One., 10(10), e0141266, Oct. 2015

  DOI
• Effect of depressive symptoms on the length of hospital stay among patients hospitalized for acute stroke in Japan., Sugawara N, Metoki N, Hagii J, Saito S, Shiroto H, Tomita T, Yasujima M, Okumura K, Yasui-Furukori N., Neuropsychiatr Dis Treat, 11, 2551-2556, Oct. 2015

  DOI
• The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan., Kudo S, Tomita T, Sugawara N, Sato Y, Ishioka M, Tsuruga K, Nakagami T, Nakamura K, Yasui-Furukori N., Neuropsychiatr Dis Treat., 11, 2811-2816, Oct. 2015

  DOI
• The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion., Akamine Y, Miura M, Komori H, Tamai I, Ieiri I, Yasui-Furukori N, Uno T., Drug Metab Pharmacokinet., 30(5), 352-357, Oct. 2015

  DOI
• Changes in the Temperament and Character Inventory dimensions after paroxetine treatment in patients with major depressive disorder., Tomita T, Kaneda A, Nakagami T, Kaneko S, Yasui-Furukori N., Hum Psychopharmacol., 30(5), 334-340, Sep. 2015

  DOI
• ABO Blood Type and Personality Traits in Healthy Japanese Subjects., Tsuchimine S, Saruwatari J, Kaneda A, Yasui-Furukori N., PLoS One., 10(5), e0126983, May 2015

  DOI
• Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsy., Tanamachi Y, Saruwatari J, Noai M, Kamihashi R, Soraoka H, Yoshimori Y, Ogusu N, Oniki K, Yasui-Furukori N, Ishitsu T, Nakagawa K., Neuropsychiatr Dis Treat., 11, 1007-1014, Apr. 2015

  DOI
• Dietary patterns and schizophrenia: a comparison with healthy controls., Tsuruga K, Sugawara N, Sato Y, Saito M, Furukori H, Nakagami T, Nakamura K, Takahashi I, Nakaji S, Yasui-Furukori N., Neuropsychiatr Dis Treat., 11, 1115-1120, Apr. 2015

  DOI
• Relationship between dietary patterns and cognitive function in a community-dwelling population in Japan., Sugawara N, Yasui-Furukori N, Umeda T, Tsuchimine S, Kaneda A, Tsuruga K, Iwane K, Okubo N, Takahashi I, Kaneko S., Asia Pac J Public Health., 27(2), NP2651-NP2660, Mar. 2015

  DOI
• Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers., Ishioka M, Yasui-Furukori N, Sugawara N, Furukori H, Kudo S, Nakamura K., Neuropsychiatr Dis Treat., 11, 477-484, Feb. 2015

  DOI
• Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers., Akamine Y, Miura M, Yasui-Furukori N, Ieiri I, Uno T., J Clin Pharm Ther., 40(1), 98-103, Feb. 2015

  DOI
• Effects of the 2004 postgraduate training program on the interprefectural distribution of psychiatrists in Japan., Sugawara N, Tanaka O, Yasui-Furukori N., Psychiatry Clin Neurosci., 69(2), 117-121, Feb. 2015

  DOI
• The relationships between androgens and novelty seeking in healthy Japanese men., Tsuchimine S, Kaneda A, Nakamura K, Yasui-Furukori N., Psychiatry Res., 225(1-2), 175-178, Jan. 2015

  DOI
• Effects of age on paroxetine efficacy in patients with major depressive disorder who do not exhibit an early response to treatment., Tomita T, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S, Nakamura K, Yasui-Furukori N., Clin Neuropharmacol., 38(1), 6-10, Jan. 2015

  DOI
• Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression., Tsuchimine S, Saito M, Kaneko S, Yasui-Furukori N., Psychiatry Res., 225(1-2), 187-190, Jan. 2015

  DOI
• Prevalence and Predictive Factors of Irritable Bowel Syndrome in a Community-dwelling Population in Japan., Satake R, Sugawara N, Sato K, Takahashi I, Nakaji S, Yasui-Furukori N, Fukuda S., Intern Med., 54(24), 3105-3112, Jan. 2015

  DOI
• Age and gender differences in the factor structure of the Center for Epidemiological Studies Depression Scale among Japanese working individuals., ugawara N, Yasui-Furukori N, Takahashi I, Matsuzaka M, Nakaji S., Compr Psychiatry, 56, 272-278, Jan. 2015

  DOI
• High-density lipoprotein-cholesterol and antipsychotic medication in overweight inpatients with schizophrenia: post-hoc analysis of a Japanese nationwide survey., Ono Shin;Sugai Takuro;Suzuki Yutaro;Yamazaki Manabu;Shimoda Kazutaka;Mori Takao;Ozeki Yuji;Matsuda Hiroshi;Sugawara Norio;Yasui-Furukori Norio;Okamoto Kurefu;Sagae Toyoaki;Someya Toshiyuki, BMC psychiatry, 18(1), 180, 2018

  DOIPermalink
• Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation., Tomita Tetsu;Kudo Shuhei;Sugawara Norio;Fujii Akira;Tsuruga Koji;Sato Yasushi;Ishioka Masamichi;Nakamura Kazuhiko;Yasui-Furukori Norio, Neuropsychiatric disease and treatment, 15, 3069-3078, 2019

  DOIPermalink
• Personality Traits Do Not Have Influence on Glycemic Control in Outpatients with Type 2 Diabetes Mellitus., Yasui-Furukori Norio;Murakami Hiroshi;Otaka Hideyuki;Tanabe Jutaro;Yanagimachi Miyuki;Murabayashi Masaya;Matsumura Koki;Matsuhashi Yuki;Nakayama Hirofumi;Mizushiri Satoru;Sugawara Norio;Daimon Makoto;Shimoda Kazutaka, Psychiatry investigation, 17(1), 78-84, Jan. 2020

  DOIPermalink
• Coping styles associated with glucose control in individuals with type 2 diabetes mellitus., Murakami Hiroshi;Yasui-Furukori Norio;Otaka Hideyuki;Nakayama Hirofumi;Murabayashi Masaya;Mizushiri Satoru;Matsumura Koki;Tanabe Jutaro;Matsuhashi Yuki;Yanagimachi Miyuki;Sugawara Norio;Shimoda Kazutaka;Daimon Makoto, Journal of diabetes investigation, 11(5), 1215-1221, Sep. 2020

  DOIPermalink
• Pharmacological management of depression: Japanese expert consensus., Sakurai Hitoshi;Uchida Hiroyuki;Kato Masaki;Suzuki Takefumi;Baba Hajime;Watanabe Koichiro;Inada Ken;Kikuchi Toshiaki;Katsuki Asuka;Kishida Ikuko;Sugawara Kikuchi Yuka;Yasui-Furukori Norio; , Journal of affective disorders, 266, 626-632, 2020

  DOIPermalink
• Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI)., Tsuboi Takashi;Suzuki Takefumi;Azekawa Takaharu;Adachi Naoto;Ueda Hitoshi;Edagawa Kouji;Katsumoto Eiichi;Kubota Yukihisa;Goto Eiichiro;Hongo Seiji;Watanabe Yoichiro;Kato Masaki;Yasui-Furukori Norio;Yoshimura Reiji;Nakagawa Atsuo;Kikuchi Toshiaki;Watanabe Koichiro, Neuropsychiatric disease and treatment, 16, 881-890, 2020

  DOIPermalink
• Working status of caregivers for people with dementia: Analysis data from a Japanese Nationwide Survey., Sugawara Norio;Yasui-Furukori Norio;Maruo Kazushi;Shimoda Kazutaka;Sumiyoshi Tomiki, PloS one, 15(5), e0232787, 2020

  DOIPermalink
• Association Between the Serum Carnitine Level and Ammonia and Valproic Acid Levels in Patients with Bipolar Disorder., Yokoyama Saaya;Yasui-Furukori Norio;Nakagami Taku;Miyazaki Kensuke;Ishioka Masamichi;Tarakita Natsumi;Kubo Kazutoshi;Sugawara Norio;Shimoda Kazutaka, Therapeutic drug monitoring, 42(5), 766-770, 2020

  DOIPermalink
• Pharmacological management of bipolar disorder: Japanese expert consensus., Sakurai Hitoshi;Kato Masaki;Yasui-Furukori Norio;Suzuki Takefumi;Baba Hajime;Watanabe Koichiro;Inada Ken;Kishida Ikuko;Sugawara Kikuchi Yuka;Kikuchi Toshiaki;Katsuki Asuka;Uchida Hiroyuki; , Bipolar disorders, 22(8), 822-830, 2020

  DOIPermalink
• The associations of the number of medications and the use of anticholinergics with recovery from tubal feeding: a longitudinal hospital-based study., Takata Keiji;Oniki Kentaro;Tateyama Yuki;Yasuda Hiroki;Yokota Miu;Yamauchi Sae;Sugawara Norio;Yasui-Furukori Norio;Saruwatari Junji, BMC geriatrics, 20(1), 373, 2020

  DOIPermalink
• Factor structure of the University Personality Inventory in Japanese medical students., Sugawara Norio;Yasui-Furukori Norio;Sayama Masayuki;Shimoda Kazutaka, BMC psychology, 8(1), 103, 01 Oct. 2020

  DOIPermalink
• Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI)., Kato Masaki;Adachi Naoto;Kubota Yukihisa;Azekawa Takaharu;Ueda Hitoshi;Edagawa Kouji;Katsumoto Eiichi;Goto Eiichiro;Hongo Seiji;Tsuboi Takashi;Yasui-Furukori Norio;Yoshimura Reiji;Nakagawa Atsuo;Kikuchi Toshiaki;Kinoshita Toshihiko;Watanabe Youichiro;Miki Kazuhira;Watanabe Koichiro, Journal of psychiatric research, 131, 228-234, 2020

  DOIPermalink
• Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan., Sugawara Norio;Yasui-Furukori Norio;Yamazaki Manabu;Shimoda Kazutaka;Mori Takao;Sugai Takuro;Matsuda Hiroshi;Suzuki Yutaro;Ozeki Yuji;Okamoto Kurefu;Sagae Toyoaki;Someya Toshiyuki, Neuropsychiatric disease and treatment, 16, 2229-2236, 2020

  DOIPermalink
• Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study., Adachi Naoto;Azekawa Takaharu;Edagawa Kouji;Goto Eiichiro;Hongo Seiji;Kato Masaki;Katsumoto Eiichi;Kikuchi Toshiaki;Kubota Yukihisa;Miki Kazuhira;Nakagawa Atsuo;Tsuboi Takashi;Ueda Hitoshi;Watanabe Koichiro;Watanabe Yoichiro;Yasui-Furukori Norio;Yoshimura Reiji, Human psychopharmacology, 36(2), e2764, Mar. 2021

  DOIPermalink
• Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder., Yasui-Furukori Norio;Adachi Naoto;Kubota Yukihisa;Azekawa Takaharu;Goto Eiichiro;Edagawa Koji;Katsumoto Eiichi;Hongo Seiji;Ueda Hitoshi;Miki Kazuhira;Kato Masaki;Yoshimura Reiji;Nakagawa Atsuo;Kikuchi Toshiaki;Tsuboi Takashi;Watanabe Koichiro;Shimoda Kazutaka, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 18(4), 599-606, 30 Nov. 2020

  DOIPermalink
• Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder., Tokumitsu Keita;Yasui-Furukori Norio;Adachi Naoto;Kubota Yukihisa;Watanabe Yoichiro;Miki Kazuhira;Azekawa Takaharu;Edagawa Koji;Katsumoto Eiichi;Hongo Seiji;Goto Eiichiro;Ueda Hitoshi;Kato Masaki;Yoshimura Reiji;Nakagawa Atsuo;Kikuchi Toshiaki;Tsuboi Takashi;Shimoda Kazutaka;Watanabe Koichiro, BMC psychiatry, 20(1), 555, 2020

  DOIPermalink
• Relationship of Prolactin Concentrations to Steady-state Plasma Concentrations of Aripiprazole in Schizophrenia Patients., Tasaki Minami;Yasui-Furukori Norio;Kubo Kazuyoshi;Yokoyama Saaya;Shinozaki Masataka;Sugawara Norio;Inoue Yoshimasa;Shimoda Kazutaka, Therapeutic drug monitoring, 20 Nov. 2020

  DOIPermalink
• Effects of CYP2D6 Genotypes on Venlafaxine Metabolism in Japanese Psychiatric Patients with Depression., Komahashi-Sasaki Hazuki;Yasui-Furukori Norio;Sasaki Taro;Shinozaki Masataka;Hayashi Yuki;Kato Kazuko;Inoue Yoshimasa;Tsuchimine Shoko;Watanabe Takashi;Sugawara Norio;Shimoda Kazutaka, Therapeutic drug monitoring, 09 Dec. 2020

  DOIPermalink
• The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms., Sugawara Norio;Yasui-Furukori Norio;Tsuji Toshinaga;Hayashi Shinji;Ajisawa Yoshikazu;Ochiai Toshimitsu;Imagawa Hideyuki;Shimoda Kazutaka, Neuropsychiatric disease and treatment, 16, 3063-3070, 2020

  DOIPermalink
• Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus., Sakurai Hitoshi;Yasui-Furukori Norio;Suzuki Takefumi;Uchida Hiroyuki;Baba Hajime;Watanabe Koichiro;Inada Ken;Kikuchi Yuka Sugawara;Kikuchi Toshiaki;Katsuki Asuka;Kishida Ikuko;Kato Masaki, Pharmacopsychiatry, 54(2), 60-67, Mar. 2021

  DOIPermalink
• CYP2D6*10 polymorphism and the enantioselective O-desmethylation of S-(+)- and R-(-)-venlafaxine in Japanese psychiatric patients., Sasaki Taro;Yasui-Furukori Norio;Komahashi-Sasaki Hazuki;Shinozaki Masataka;Hayashi Yuki;Kato Kazuko;Inoue Yoshimasa;Tsuchimine Shoko;Watanabe Takashi;Sugawara Norio;Shimoda Kazutaka, Basic & clinical pharmacology & toxicology, 128(5), 677-685, May 2021

  DOIPermalink
• Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval., Okayasu Hiroaki;Shinozaki Takahiro;Takano Yumiko;Sugawara Norio;Fujii Kumiko;Yasui-Furukori Norio;Ozeki Yuji;Shimoda Kazutaka, Neuropsychiatric disease and treatment, 17, 239-249, 2021

  DOIPermalink
• The combination of MMSE with VSRAD and eZIS has greater accuracy for discriminating mild cognitive impairment from early Alzheimer's disease than MMSE alone., Tokumitsu Keita;Yasui-Furukori Norio;Takeuchi Junko;Yachimori Koji;Sugawara Norio;Terayama Yoshio;Tanaka Nobuyuki;Naraoka Tatsunori;Shimoda Kazutaka, PloS one, 16(2), e0247427, 2021

  DOIPermalink
• Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study., Numata Shusuke;Nakataki Masahito;Hasegawa Naomi;Takaesu Yoshikazu;Takeshima Masahiro;Onitsuka Toshiaki;Nakamura Toshinori;Edagawa Reon;Edo Hiroaki;Miura Kenichiro;Matsumoto Junya;Yasui-Furukori Norio;Kishimoto Taishiro;Hori Hikaru;Tsuboi Takashi;Yasuda Yuka;Furihata Ryuji;Muraoka Hiroyuki;Ochi Shinichiro;Nagasawa Tatsuya;Kyou Yoshitaka;Murata Atsunobu;Katsumoto Eiichi;Ohi Kazutaka;Hishimoto Akitoyo;Inada Ken;Watanabe Koichiro;Hashimoto Ryota, Neuropsychopharmacology reports, 11 Mar. 2021

  DOIPermalink
• Projections of psychiatrists' distribution for patients in Japan: a utilization-based approach., Sugawara Norio;Yasui-Furukori Norio;Shimoda Kazutaka, Human resources for health, 19(1), 49, 09 Apr. 2021

  DOIPermalink
• Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment., Kawamata Yasushi;Sugawara Norio;Ishioka Masamichi;Kubo Kazutoshi;Suzuki Katsuji;Fujii Akira;Furukori Hanako;Nakagami Taku;Yasui-Furukori Norio;Shimoda Kazutaka, Neuropsychiatric disease and treatment, 17, 1927-1936, 2021

  DOIPermalink
• Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels., Tasaki Minami;Yasui-Furukori Norio;Yokoyama Saaya;Shinozaki Masataka;Sugawara Norio;Shimoda Kazutaka, Neuropsychopharmacology reports, 41(3), 379-384, 2021

  DOIPermalink
• Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms., Takeuchi Hiroyoshi;Takekita Yoshiteru;Hori Hikaru;Oya Kazuto;Miura Itaru;Hashimoto Naoki;Yasui-Furukori Norio, Human psychopharmacology, 36(6), e2804, 2021

  DOIPermalink
• Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project., Hashimoto Naoki;Yasui-Furukori Norio;Hasegawa Naomi;Ishikawa Shuhei;Numata Shusuke;Hori Hikaru;Iida Hitoshi;Ichihashi Kayo;Furihata Ryuji;Murata Atsunobu;Tsuboi Takashi;Takeshima Masahiro;Kyou Yoshitaka;Komatsu Hiroshi;Kubota Chika;Ochi Shinichiro;Takaesu Yoshikazu;Usami Masahide;Nagasawa Tatsuya;Hishimoto Akitoyo;Miura Kenichiro;Matsumoto Junya;Ohi Kazutaka;Yamada Hisashi;Inada Ken;Watanabe Koichiro;Shimoda Kazutaka;Hashimoto Ryota, Asian journal of psychiatry, 63, 102744, Sep. 2021

  DOIPermalink
• Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project., Konno Yusuke;Fujino Yoshihisa;Ikenouchi Atsuko;Adachi Naoto;Kubota Yukihisa;Azekawa Takaharu;Ueda Hitoshi;Edagawa Koji;Katsumoto Eiichi;Goto Eiichiro;Hongo Seiji;Kato Masaki;Tsuboi Takashi;Yasui-Furukori Norio;Nakagawa Atsuo;Kikuchi Toshiaki;Watanabe Koichiro;Yoshimura Reiji, Neuropsychiatric disease and treatment, 17, 2867-2876, 2021

  DOIPermalink
• Attitudes of Medical Students toward COVID-19 Vaccination: Who Is Willing to Receive a Third Dose of the Vaccine?, Sugawara Norio;Yasui-Furukori Norio;Fukushima Atsuhito;Shimoda Kazutaka, Vaccines, 9(11), 08 Nov. 2021

  DOIPermalink
• Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey., Shinozaki Masataka;Yasui-Furukori Norio;Adachi Naoto;Ueda Hitoshi;Hongo Seiji;Azekawa Takaharu;Kubota Yukihisa;Katsumoto Eiichi;Edagawa Koji;Goto Eiichiro;Miki Kazuhira;Kato Masaki;Nakagawa Atsuo;Kikuchi Toshiaki;Tsuboi Takashi;Watanabe Koichiro;Shimoda Kazutaka;Yoshimura Reiji, Asian journal of psychiatry, 67, 102935, Jan. 2022

  DOIPermalink
• Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study., Yasui-Furukori Norio;Muraoka Hiroyuki;Hasegawa Naomi;Ochi Shinichiro;Numata Shusuke;Hori Hikaru;Hishimoto Akitoyo;Onitsuka Toshiaki;Ohi Kazutaka;Hashimoto Naoki;Nagasawa Tatsuya;Takaesu Yoshikazu;Inagaki Takahiko;Tagata Hiromi;Tsuboi Takashi;Kubota Chika;Furihata Ryuji;Iga Jun-Ichi;Iida Hitoshi;Miura Kenichiro;Matsumoto Junya;Yamada Hisashi;Watanabe Koichiro;Inada Ken;Shimoda Kazutaka;Hashimoto Ryota, Neuropsychopharmacology reports, 42(1), 3-9, 2022

  DOIPermalink
• Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study., Sugawara Norio;Yasui-Furukori Norio;Maruo Kazushi;Shimoda Kazutaka;Sumiyoshi Tomiki, Journal of Alzheimer's disease : JAD, 85(2), 667-674, 2022

  DOIPermalink
• Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study., Furihata Ryuji;Otsuki Rei;Hasegawa Naomi;Tsuboi Takashi;Numata Shusuke;Yasui-Furukori Norio;Kashiwagi Hiroko;Hori Hikaru;Ochi Shinichiro;Muraoka Hiroyuki;Onitsuka Toshiaki;Komatsu Hiroshi;Takeshima Masahiro;Hishimoto Akitoyo;Nagasawa Tatsuya;Takaesu Yoshikazu;Nakamura Toshinori;Asami Takeshi;Miura Kenichiro;Matsumoto Junya;Ohi Kazutaka;Yasuda Yuka;Iida Hitoshi;Ogasawara Kazuyoshi;Hashimoto Naoki;Ichihashi Kayo;Yamada Hisashi;Watanabe Koichiro;Inada Ken;Hashimoto Ryota, Sleep medicine, 89, 23-30, Jan. 2022

  DOIPermalink
• Serial case report of high seizure threshold patients that responded to the lengthening of pulse width in ECT., Katagai Hiroshi;Yasui-Furukori Norio;Kawashima Hirotsugu;Suwa Taro;Tsushima Chieko;Sato Yoshiteru;Shimoda Kazutaka;Tasaki Hiroichi, Neuropsychopharmacology reports, 42(1), 105-108, 2022

  DOIPermalink
• Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder., Tokumitsu Keita;Norio Yasui-Furukori;Adachi Naoto;Kubota Yukihisa;Watanabe Yoichiro;Miki Kazuhira;Azekawa Takaharu;Edagawa Koji;Katsumoto Eiichi;Hongo Seiji;Goto Eiichiro;Ueda Hitoshi;Kato Masaki;Nakagawa Atsuo;Kikuchi Toshiaki;Tsuboi Takashi;Watanabe Koichiro;Shimoda Kazutaka;Yoshimura Reiji, PloS one, 16(12), e0262129, 2021

  DOIPermalink
• The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project., Ichihashi Kayo;Kyou Yoshitaka;Hasegawa Naomi;Yasui-Furukori Norio;Shimizu Yoshihito;Hori Hikaru;Hashimoto Naoki;Ide Kenta;Imamura Yayoi;Yamada Hisashi;Ochi Shinichiro;Iga Jun-Ichi;Takaesu Yoshikazu;Ohi Kazutaka;Tsuboi Takashi;Iida Hitoshi;Yamagata Hirotaka;Hishimoto Akitoyo;Horai Tadasu;Usami Masahide;Makinodan Manabu;Nagasawa Tatsuya;Komatsu Hiroshi;Kido Mikio;Muraoka Hiroyuki;Atake Kiyokazu;Takeshima Masahiro;Kubota Chika;Inagaki Takahiko;Tamai Shinichiro;Kishimoto Taishiro;Furihata Ryuji;Matsumoto Junya;Miura Kenichiro;Inada Ken;Watanabe Koichiro;Kasai Kiyoto;Hashimoto Ryota, Asian journal of psychiatry, 69, 103007, Mar. 2022

  DOIPermalink
• Relationship Between Employment Status and Unstable Periods in Outpatients with Bipolar Disorder: A Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI) Study., Ikenouchi Atsuko;Konno Yusuke;Fujino Yoshihisa;Adachi Naoto;Kubota Yukihisa;Azekawa Takaharu;Ueda Hitoshi;Edagawa Koji;Katsumoto Eiichi;Goto Eiichiro;Hongo Seiji;Kato Masaki;Tsuboi Takashi;Yasui-Furukori Norio;Nakagawa Atsuo;Kikuchi Toshiaki;Watanabe Koichiro;Yoshimura Reiji, Neuropsychiatric disease and treatment, 18, 801-809, 08 Apr. 2022

  DOIPermalink
• A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project., Yamada Hisashi;Motoyama Mikuni;Hasegawa Naomi;Miura Kenichiro;Matsumoto Junya;Ohi Kazutaka;Yasui-Furukori Norio;Numata Shusuke;Takeshima Masahiro;Sugiyama Nobuhiro;Nagasawa Tatsuya;Kubota Chika;Atake Kiyokazu;Tsuboi Takashi;Ichihashi Kayo;Hashimoto Naoki;Inagaki Takahiko;Takaesu Yoshikazu;Iga Jun-Ichi;Hori Hikaru;Onitsuka Toshiaki;Komatsu Hiroshi;Hishimoto Akitoyo;Fukumoto Kentaro;Fujimoto Michiko;Nakamura Toshinori;Nemoto Kiyotaka;Furihata Ryuji;Yamamura Satoshi;Yamagata Hirotaka;Ogasawara Kazuyoshi;Katsumoto Eiichi;Murata Atsunobu;Iida Hitoshi;Ochi Shinichiro;Makinodan Manabu;Kido Mikio;Kishimoto Taishiro;Yasuda Yuka;Usami Masahide;Suwa Taro;Inada Ken;Watanabe Koichiro;Hashimoto Ryota, BJPsych open, 8(3), e83, 21 Apr. 2022

  DOIPermalink

Review paper
• [The Drug Interaction that Psychiatrists Should be Careful about]., Yasui-Furukori Norio, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 118(3), 152-158, 2016

  Permalink
• Prevalence of perinatal depression among Japanese women: a meta-analysis., Tokumitsu Keita;Sugawara Norio;Maruo Kazushi;Suzuki Toshihito;Shimoda Kazutaka;Yasui-Furukori Norio, Annals of general psychiatry, 19, 41, 2020

  DOIPermalink
• Prevalence of perinatal depression among Japanese men: a meta-analysis., Tokumitsu Keita;Sugawara Norio;Maruo Kazushi;Suzuki Toshihito;Yasui-Furukori Norio;Shimoda Kazutaka, Annals of general psychiatry, 19(1), 65, 18 Nov. 2020

  DOIPermalink
• Toward recovery in schizophrenia: Current concepts, findings, and future research directions., Onitsuka Toshiaki;Hirano Yoji;Nakazawa Takanobu;Ichihashi Kayo;Miura Kenichiro;Inada Ken;Mitoma Ryo;Yasui-Furukori Norio;Hashimoto Ryota, Psychiatry and clinical neurosciences, 76(7), 282-291, 01 Apr. 2022

  DOIPermalink

Case report
• Secondary oxalosis induced by xylitol concurrent with lithium-induced nephrogenic diabetes insipidus: a case report., Takayasu Shinobu;Kamba Aya;Yoshida Kazutaka;Terui Ken;Watanuki Yutaka;Ishigame Noriko;Mizushiri Satoru;Tomita Tetsu;Nakamura Kazuhiko;Yasui-Furukori Norio;Daimon Makoto, BMC nephrology, 21(1), 157, 2020

  DOIPermalink
• Successful Treatment With Lithium in a Refractory Patient With Periodic Catatonic Features: A Case Report., Sato Yoshiteru;Shinozaki Masataka;Okayasu Hiroaki;Yasui-Furukori Norio;Shimoda Kazutaka, Clinical neuropharmacology, 43(3), 84-85, Mar. 2020

  DOIPermalink
• Bickerstaff's Brainstem Encephalitis Suspected as Functional Neurologic Disorders., Okayasu Hiroaki;Yasui-Furukori Norio;Kadowaki Taro;Funakoshi Kei;Hirata Koichi;Shimoda Kazutaka, International medical case reports journal, 13, 177-181, 2020

  DOIPermalink
• Gluten-Related Disorder and Lactose Intolerance Concomitant With Avoidant/Restrictive Food Intake Disorder., Sato Yoshiteru;Shinozaki Masataka;Sasaki Hazuki;Shiinoki Makiko;Shimizu Taro;Yasui-Furukori Norio;Shimoda Kazutaka, The primary care companion for CNS disorders, 22(4), 2020

  DOIPermalink
• Clozapine-associated severe eosinophilia following lithium rebound neutropenia: A case report., Kikuchi Kota;Yasui-Furukori Norio;Yokoyama Saaya;Hasegawa Chie;Kokubun Atsuhiko;Katsukura Shinichi;Shimizu Taro;Shimoda Kazutaka, Neuropsychopharmacology reports, 40(4), 388-391, 2020

  DOIPermalink
• Heidenhain variant of Creutzfeldt-Jakob disease resembles dementia with Lewy bodies., Tokumitsu Keita;Oyama Shigeto;Takeuchi Junko;Yachimori Koji;Sugawara Norio;Yasui-Furukori Norio;Shimoda Kazutaka, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 21(1), 121-124, 2021

  DOIPermalink
• Transient glyphosate encephalopathy due to a suicide attempt., Yokoyama Saaya;Sugisaki Tomomi;Ryota Yoshida;Yoshiteru Sato;Okayasu Hiroaki;Shioda Mukuto;Suzuki Keisuke;Yasui-Furukori Norio;Shimoda Kazutaka, Neuropsychopharmacology reports, 41(3), 444-447, 2021

  DOIPermalink
• A pregnant woman who experienced auditory hallucinations concurrent with hyperemesis gravidarum: A case report., Okayasu Hiroaki;Yasui-Furukori Norio;Shimoda Kazutaka, Neuropsychopharmacology reports, 41(4), 548-550, 2021

  DOIPermalink
• Takotsubo cardiomyopathy after hypoglycemia in a patient with anorexia nervosa., Kikuchi Kota;Yasui-Furukori Norio;Hasegawa Chie;Watahiki Manami;Inoue Teruo;Shimoda Kazutaka, Annals of general psychiatry, 20(1), 39, 04 Sep. 2021

  DOIPermalink
• Suicide attempt induced by drug-induced leukoencephalopathy: A case report., Maehara Ryo;Kawamata Yasushi;Ichikawa Motoshi;Mitani Kinuko;Yasui-Furukori Norio;Shimoda Kazutaka, Neuropsychopharmacology reports, 41(4), 551-553, 2021

  DOIPermalink

Other
• Difficult differentiation of a somatic symptom disorder from anterior cutaneous nerve entrapment syndrome (ACNES): a case report., Yokoyama N, Shiraki R, Watanabe T, Shiinoki M, Nin M, Shimizu T, Yasui-Furukori N, Shimoda K., BMC Psychiatry., 19(1), 394, Dec. 2019

  DOI
• Insulinoma resembling a rapid eye movement sleep behavior disorder: a case report., Kishi K, Kubo K, Tomita T, Nakamura K, Yasui-Furukori N., Int Med Case Rep J., 12, 51-54, Feb. 2019

  DOI
• Suvorexant-Induced Delirium., Yoshida K, Nakamura K, Yasui-Furukori N., Prim Care Companion CNS Disord., 20(6), 18l02297, Nov. 2018

  DOI
• Tandospirone-Induced Rhabdomyolysis., Miyazaki K, Otaka M, Yasui-Furukori N., Clin Neuropharmacol., 41(6), 216-217, Nov. 2018

  DOI
• Levodopa-responsive depression associated with corticobasal degeneration: a case report., Tarakita N, Nishijima H, Yasui-Furukori N., Neuropsychiatr Dis Treat., 13, 1107-1110, Apr. 2017

  DOI
• Bipolar disorder recurrence prevention using self-monitoring daily mood charts: case reports from a 5 year period., Yasui-Furukori N, Nakamura K., Neuropsychiatr Dis Treat., 13, 733-736, Mar. 2017

  DOI
• Cardiac sarcoidosis resembling panic disorder: a case report., Tokumitsu K, Demachi J, Yamanoi Y, Oyama S, Takeuchi J, Yachimori K, Yasui-Furukori N., BMC Psychiatry., 17(1), 14, Jan. 2017

  DOI
• Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report., Sato Y, Nakamura K, Yasui-Furukori N., Neuropsychiatr Dis Treat., 11, 2505-2507, Sep. 2015

  DOI
• Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine., Akamine Y, Uehara H, Miura M, Yasui-Furukori N, Uno T., J Clin Pharm Ther., 40(4), 480-482, Aug. 2015

  DOI
• Drug-Drug Interactions of P-gp Substrates Unrelated to CYP Metabolism., Akamine Y, Yasui-Furukori N, Uno T., Curr Drug Metab., 20(2), 124-129, Feb. 2019

  DOI
• Competence to Consent and Its Relationship With Cognitive Function in Patients With Schizophrenia., Sugawara N, Yasui-Furukori N, Sumiyoshi T., Front Psychiatry., 10, 195, 2019

  DOI
• Prevalence of underweight in patients with schizophrenia: A meta-analysis., Sugawara N, Maruo K, Sugai T, Suzuki Y, Ozeki Y, Shimoda K, Someya T, Yasui-Furukori N., Schizophr Res., 195, 67-73, May 2018

  DOI
• Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia., Yasui-Furukori Norio;Shimoda Kazutaka, Neuropsychopharmacology reports, 40(3), 208-210, 2020

  DOIPermalink
• Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study., Iida Hitoshi;Iga Junichi;Hasegawa Naomi;Yasuda Yuka;Yamamoto Tomoya;Miura Kenichiro;Matsumoto Junya;Murata Atsunobu;Ogasawara Kazuyoshi;Yamada Hisashi;Hori Hikaru;Ichihashi Kayo;Hashimoto Naoki;Ohi Kazutaka;Yasui-Furukori Norio;Tsuboi Takashi;Nakamura Toshinori;Usami Masahide;Furihata Ryuji;Takaesu Yoshikazu;Iwamoto Kunihiro;Sugiyama Nobuhiro;Kishimoto Taishiro;Tsujino Naohisa;Yamada Hiroki;Hishimoto Akitoyo;Nemoto Kiyotaka;Atake Kiyokazu;Muraoka Hiroyuki;Katsumoto Eiichi;Oishi Satoru;Inagaki Takahiko;Ito Fumiaki;Imamura Yayoi;Kido Mikio;Nagasawa Tatsuya;Numata Shusuke;Ochi Shinichiro;Iwata Masaaki;Yamamori Hidenaga;Fujita Junichi;Onitsuka Toshiaki;Yamamura Satoshi;Makinodan Manabu;Fujimoto Michiko;Takayanagi Yoichiro;Takezawa Kenji;Komatsu Hiroshi;Fukumoto Kentaro;Tamai Shinichiro;Yamagata Hirotaka;Kubota Chika;Horai Tadasu;Inada Ken;Watanabe Koichiro;Kawasaki Hiroaki;Hashimoto Ryota, Psychiatry and clinical neurosciences, 74(12), 667-669, Dec. 2020

  DOIPermalink

Unclear
• Carbamazepine decreases antihypertensive effect of nilvadipine., Yasui-Furukori Norio;Tateishi Tomonori, Journal of clinical pharmacology, 42(1), 100-103, Jan. 2002

  DOIPermalink
• Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin., Kondo Tsuyoshi;Ishida Masayuki;Tokinaga Noboru;Mihara Kazuo;Yasui-Furukori Norio;Ono Shingo;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 26(2), 287-291, Feb. 2002

  DOIPermalink
• Therapeutic effects of bromperidol on the five dimensions of schizophrenic symptoms., Yasui-Furukori Norio;Kondo Tsuyoshi;Ishida Masayuki;Furukori Hanako;Suzuki Akihito;Kaneko Sunao;Inoue Masayoshi;Otani Koichi, Progress in neuro-psychopharmacology & biological psychiatry, 26(1), 53-57, Jan. 2002

  DOIPermalink
• Determination of donepezil, an acetylcholinesterase inhibitor, in human plasma by high-performance liquid chromatography with ultraviolet absorbance detection., Yasui-Furukori Norio;Furuya Rie;Takahata Takenori;Tateishi Tomonori, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 768(2), 261-265, 05 Mar. 2002

  DOIPermalink
• The characteristics of side-effects of bromperidol in schizophrenic patients., Yasui-Furukori Norio;Kondo Tsuyoshi;Ishida Masayuki;Tanaka Osamu;Mihara Kazuo;Kaneko Sunao;Otani Koichi, Psychiatry and clinical neurosciences, 56(1), 103-106, Feb. 2002

  DOIPermalink
• Comparison of prolactin concentrations between haloperidol and bromperidol treatments in schizophrenic patients., Yasui-Furukori Norio;Kondo Tsuyoshi;Suzuki Akihito;Mihara Kazuo;Kaneko Sunao;Otani Koichi, Progress in neuro-psychopharmacology & biological psychiatry, 26(3), 575-578, Apr. 2002

  DOIPermalink
• Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes., Ono Shingo;Mihara Kazuo;Suzuki Akihito;Kondo Tsuyoshi;Yasui-Furukori Norio;Furukori Hanako;de Vries Ronald;Kaneko Sunao, Psychopharmacology, 162(1), 50-54, Jun. 2002

  DOIPermalink
• Comparison of prolactin concentrations between haloperidol and risperidone treatments in the same female patients with schizophrenia., Yasui-Furukori Norio;Kondo Tsuyoshi;Suzuki Akihito;Mihara Kazuo;Kaneko Sunao, Psychopharmacology, 162(1), 63-66, Jun. 2002

  DOIPermalink
• Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients., Mihara Kazuo;Yasui-Furukori Norio;Kondo Tsuyoshi;Ishida Masayuki;Ono Shingo;Ohkubo Tadashi;Osanai Takako;Sugawara Kazunobu;Otani Koichi;Kaneko Sunao, Therapeutic drug monitoring, 24(4), 563-566, Aug. 2002

  DOIPermalink
• Lack of correlation between the steady-state plasma concentrations of haloperidol and risperidone., Yasui-Furukori Norio;Kondo Tsuyoshi;Mihara Kazuo;Suzuki Akihito;Inoue Yoshimasa;De Vries Ronald;Kaneko Sunao, Journal of clinical pharmacology, 42(10), 1083-1088, Oct. 2002

  DOIPermalink
• Effect of dietary fat content in meals on pharmacokinetics of quazepam., Yasui-Furukori Norio;Kondo Tsuyoshi;Takahata Takenori;Mihara Kazuo;Ono Shingo;Kaneko Sunao;Tateishi Tomonori, Journal of clinical pharmacology, 42(12), 1335-1340, Dec. 2002

  DOIPermalink
• Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome., Mihara Kazuo;Kondo Tsuyoshi;Suzuki Akihito;Yasui-Furukori Norio;Ono Shingo;Sano Akira;Koshiro Kazuko;Otani Koichi;Kaneko Sunao, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 117B(1), 57-60, Feb. 2003

  DOIPermalink
• Effects of CYP2D6 genotypes on plasma concentrations of risperidone and enantiomers of 9-hydroxyrisperidone in Japanese patients with schizophrenia., Yasui-Furukori Norio;Mihara Kazuo;Kondo Tsuyoshi;Kubota Takahiro;Iga Tatsuji;Takarada Yutaka;De Vries Ronald;Kaneko Sunao;Tateishi Tomonori, Journal of clinical pharmacology, 43(2), 122-127, Feb. 2003

  DOIPermalink
• Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects., Takahata Takenori;Yasui-Furukori Norio;Sasaki Shingo;Igarashi Tomonori;Okumura Ken;Munakata Akihiro;Tateishi Tomonori, Life sciences, 72(21), 2391-2399, 11 Apr. 2003

  DOIPermalink
• Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol., Suzuki Akihito;Yasui-Furukori Norio;Mihara Kazuo;Kondo Tsuyoshi;Furukori Hanako;Inoue Yoshimasa;Kaneko Sunao;Otani Koichi, Therapeutic drug monitoring, 25(2), 192-196, Apr. 2003

  DOIPermalink
• Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam., Yasui-Furukori Norio;Takahata Takenori;Kondo Tsuyoshi;Mihara Kazuo;Kaneko Sunao;Tateishi Tomonori, British journal of clinical pharmacology, 55(4), 382-388, Apr. 2003

  DOIPermalink
• Determination of a new atypical antipsychotic agent perospirone and its metabolite in human plasma by automated column-switching high-performance liquid chromatography., Yasui-Furukori Norio;Inoue Yoshimasa;Tateishi Tomonori, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 789(2), 239-245, 15 Jun. 2003

  DOIPermalink
• Effects of various CYP2D6 genotypes on the steady-state plasma concentrations of risperidone and its active metabolite, 9-hydroxyrisperidone, in Japanese patients with schizophrenia., Mihara Kazuo;Kondo Tsuyoshi;Yasui-Furukori Norio;Suzuki Akihito;Ishida Masayuki;Ono Shingo;Kubota Takahiro;Iga Tatsuji;Takarada Yutaka;de Vries Ronald;Kaneko Sunao, Therapeutic drug monitoring, 25(3), 287-293, Jun. 2003

  DOIPermalink
• Effects of itraconazole on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug., Kato Kimiyasu;Yasui-Furukori Norio;Fukasawa Takashi;Aoshima Toshiaki;Suzuki Akihito;Kanno Muneaki;Otani Koichi, Therapeutic drug monitoring, 25(4), 473-477, Aug. 2003

  DOIPermalink
• Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia., Yasui-Furukori Norio;Kondo Tsuyoshi;Mihara Kazuo;Inoue Yoshimasa;Kaneko Sunao, Psychopharmacology, 171(2), 223-227, Jan. 2004

  DOIPermalink
• Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes., Herrlin Karin;Yasui-Furukori Norio;Tybring Gunnel;Widén Jolanta;Gustafsson Lars L;Bertilsson Leif, British journal of clinical pharmacology, 56(4), 415-421, Oct. 2003

  DOIPermalink
• Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients., Kondo Tsuyoshi;Mihara Kazuo;Suzuki Akihito;Yasui-Furukori Norio;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 27(6), 921-926, Sep. 2003

  DOIPermalink
• Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients., Yasui-Furukori Norio;Kondo Tsuyoshi;Mihara Kazuo;Suzuki Akihito;Inoue Yoshimasa;Kaneko Sunao, Journal of clinical psychopharmacology, 23(5), 435-440, Oct. 2003

  DOIPermalink
• Interaction study between fluvoxamine and quazepam., Kanda Hideto;Yasui-Furukori Norio;Fukasawa Takashi;Aoshima Toshiaki;Suzuki Akihito;Otani Koichi, Journal of clinical pharmacology, 43(12), 1392-1397, Dec. 2003

  DOIPermalink
• Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassay., Yasui-Furukori Norio;Furukori Hanako;Saito Manabu;Inoue Yoshimasa;Kaneko Sunao;Tateishi Tomonori, Therapeutic drug monitoring, 25(6), 709-714, Dec. 2003

  DOIPermalink
• Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes., Yasui-Furukori Norio;Takahata Takenori;Nakagami Taku;Yoshiya Gen;Inoue Yoshimasa;Kaneko Sunao;Tateishi Tomonori, British journal of clinical pharmacology, 57(4), 487-494, Apr. 2004

  DOIPermalink
• Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes., Yasui-Furukori Norio;Mihara Kazuo;Takahata Takenori;Suzuki Akihito;Nakagami Taku;De Vries Ronald;Tateishi Tomonori;Kondo Tsuyoshi;Kaneko Sunao, British journal of clinical pharmacology, 57(5), 569-575, May 2004

  DOIPermalink
• The effects of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of donepezil., Yasui-Furukori Norio;Furukori Hanako;Kaneda Ayako;Kaneko Sunao;Tateishi Tomonori, Journal of clinical pharmacology, 44(5), 538-542, May 2004

  DOIPermalink
• Simultaneous determination of haloperidol and bromperidol and their reduced metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography., Yasui-Furukori Norio;Inoue Yoshimasa;Chiba Misturu;Tateishi Tomonori, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 805(1), 175-180, 05 Jun. 2004

  DOIPermalink
• Fexofenadine does not affect omeprazole pharmacokinetics: both are putative P-glycoprotein substrates., Takahata Takenori;Yasui-Furukori Norio;Yoshiya Gen;Uno Tsukasa;Sugawara Kazunobu;Tateishi Tomonori, Basic & clinical pharmacology & toxicology, 94(5), 252-256, May 2004

  DOIPermalink
• Establishment of new cloned enzyme donor immunoassays (CEDIA) for haloperidol and bromperidol., Yasui-Furukori Norio;Saito Manabu;Furukori Hanako;Inoue Yoshimasa;Someya Toshiyuki;Kaneko Sunao;Tateishi Tomonori, Therapeutic drug monitoring, 26(3), 336-341, Jun. 2004

  DOIPermalink
• Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection., Uno Tsukasa;Yasui-Furukori Norio;Takahata Takenori;Sugawara Kazunobu;Tateishi Tomonori, Journal of pharmaceutical and biomedical analysis, 35(4), 937-942, 29 Jun. 2004

  DOIPermalink
• Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response., Yasui-Furukori Norio;Furukori Hanako;Nakagami Taku;Saito Manabu;Inoue Yoshimasa;Kaneko Sunao;Tateishi Tomonori, Therapeutic drug monitoring, 26(4), 361-365, Aug. 2004

  DOIPermalink
• Single oral dose pharmacokinetics of quazepam is influenced by CYP2C19 activity., Fukasawa Takashi;Yasui-Furukori Norio;Aoshima Toshiaki;Suzuki Akihito;Tateishi Tomonori;Otani Koichi, Therapeutic drug monitoring, 26(5), 529-533, Oct. 2004

  DOIPermalink
• Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes., Yasui-Furukori Norio;Saito Masato;Uno Tsukasa;Takahata Takenori;Sugawara Kazunobu;Tateishi Tomonori, Journal of clinical pharmacology, 44(11), 1223-1229, Nov. 2004

  DOIPermalink
• Sensitive determination of midazolam and 1'-hydroxymidazolam in plasma by liquid-liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activity., Yasui-Furukori Norio;Inoue Yoshimasa;Tateishi Tomonori, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 811(2), 153-157, 25 Nov. 2004

  DOIPermalink
• Weekly paclitaxel and nedaplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer: a phase I/II study., Hasegawa Yukihiro;Takanashi Shingo;Okudera Koichi;Aoki Masahiko;Basaki Kiyoshi;Kondo Hidehiro;Takahata Takenori;Yasui-Furukori Norio;Tateishi Tomonori;Abe Yoshinao;Okumura Ken, Japanese journal of clinical oncology, 34(11), 647-653, Nov. 2004

  DOIPermalink
• Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics., Yasui-Furukori Norio;Uno Tsukasa;Sugawara Kazunobu;Tateishi Tomonori, Clinical pharmacology and therapeutics, 77(1), 17-23, Jan. 2005

  DOIPermalink
• Thioridazine inhibits risperidone metabolism: a clinically relevant drug interaction., Nakagami Taku;Yasui-Furukori Norio;Saito Manabu;Mihara Kazuo;De Vries Ronald;Kondo Tsuyoshi;Kaneko Sunao, Journal of clinical psychopharmacology, 25(1), 89-91, Feb. 2005

  DOIPermalink
• Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity., Uno Tsukasa;Yasui-Furukori Norio;Takahata Takenori;Sugawara Kazunobu;Tateishi Tomonori, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 816(1-2), 309-314, 25 Feb. 2005

  DOIPermalink
• Determination of fluvoxamine and its metabolite fluvoxamino acid by liquid-liquid extraction and column-switching high-performance liquid chromatography., Yasui-Furukori Norio;Inoue Yoshimasa;Kaneko Sunao;Otani Koichi, Journal of pharmaceutical and biomedical analysis, 37(1), 121-125, 07 Feb. 2005

  DOIPermalink
• Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes., Saito Masato;Yasui-Furukori Norio;Uno Tsukasa;Takahata Takenori;Sugawara Kazunobu;Munakata Akihiro;Tateishi Tomonori, British journal of clinical pharmacology, 59(3), 302-309, Mar. 2005

  DOIPermalink
• Effect of clarithromycin on the enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes., Miura Masatomo;Tada Hitoshi;Yasui-Furukori Norio;Uno Tsukasa;Sugawara Kazunobu;Tateishi Tomonori;Suzuki Toshio, Chirality, 17(6), 338-344, Jun. 2005

  DOIPermalink
• Lack of significant effect of grapefruit juice on the pharmacokinetics of lansoprazole and its metabolites in subjects with different CYP2C19 genotypes., Uno Tsukasa;Yasui-Furukori Norio;Takahata Takenori;Sugawara Kazunobu;Tateishi Tomonori, Journal of clinical pharmacology, 45(6), 690-694, Jun. 2005

  DOIPermalink
• Interaction study between enoxacin and fluvoxamine., Kunii Toshiki;Fukasawa Takashi;Yasui-Furukori Norio;Aoshima Toshiaki;Suzuki Akihito;Tateishi Tomonori;Inoue Yoshimasa;Otani Koichi, Therapeutic drug monitoring, 27(3), 349-353, Jun. 2005

  DOIPermalink
• Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine., Miura Masatomo;Tada Hitoshi;Yasui-Furukori Norio;Uno Tsukasa;Sugawara Kazunobu;Tateishi Tomonori;Suzuki Toshio, British journal of clinical pharmacology, 60(1), 61-68, Jul. 2005

  DOIPermalink
• Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition., Nakagami Taku;Yasui-Furukori Norio;Saito Manabu;Tateishi Tomonori;Kaneo Sunao, Clinical pharmacology and therapeutics, 78(1), 43-51, Jul. 2005

  DOIPermalink
• Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism., Tokairin Takaki;Fukasawa Takashi;Yasui-Furukori Norio;Aoshima Toshiaki;Suzuki Akihito;Inoue Yoshimasa;Tateishi Tomonori;Otani Koichi, British journal of clinical pharmacology, 60(2), 172-175, Aug. 2005

  DOIPermalink
• [Clinical pharmacogenetics in the treatment of schizophrenia]., Saito Manabu;Yasui-Furukori Norio;Kaneko Sunao, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 25(3), 129-135, Jun. 2005

  Permalink
• Determination of rabeprazole and its active metabolite, rabeprazole thioether in human plasma by column-switching high-performance liquid chromatography and its application to pharmacokinetic study., Uno Tsukasa;Yasui-Furukori Norio;Shimizu Mikiko;Sugawara Kazunobu;Tateishi Tomonori, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 824(1-2), 238-243, 25 Sep. 2005

  DOIPermalink
• The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics., Ishizawa Yukio;Yasui-Furukori Norio;Takahata Takenori;Sasaki Mutsuo;Tateishi Tomonori, Clinical pharmacokinetics, 44(11), 1179-1189, 2005

  DOIPermalink
• Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra-short-acting beta1-blocker., Takahata Takenori;Yasui-Furukori Norio;Sakamoto Juichi;Suto Koji;Suto Toshiyuki;Tateishi Tomonori;Munakata Akihiro, Drugs in R&D, 6(6), 385-394, 2005

  DOIPermalink
• Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients., Saito Manabu;Yasui-Furukori Norio;Nakagami Taku;Furukori Hanako;Kaneko Sunao, Journal of clinical psychopharmacology, 25(6), 527-532, Dec. 2005

  DOIPermalink
• Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p., Arinami Tadao;Ohtsuki Tsuyuka;Ishiguro Hiroki;Ujike Hiroshi;Tanaka Yuji;Morita Yukitaka;Mineta Mari;Takeichi Masashi;Yamada Shigeto;Imamura Akira;Ohara Koichi;Shibuya Haruo;Ohara Kenshiro;Suzuki Yasuo;Muratake Tatsuyuki;Kaneko Naoshi;Someya Toshiyuki;Inada Toshiya;Yoshikawa Takeo;Toyota Tomoko;Yamada Kazuo;Kojima Takuya;Takahashi Sakae;Osamu Ohmori;Shinkai Takahiro;Nakamura Michiko;Fukuzako Hiroshi;Hashiguchi Tomo;Niwa Shin-ich;Ueno Takuya;Tachikawa Hirokazu;Hori Takafumi;Asada Takashi;Nanko Shinichiro;Kunugi Hiroshi;Hashimoto Ryota;Ozaki Norio;Iwata Nakao;Harano Mutsuo;Arai Heii;Ohnuma Tohru;Kusumi Ichiro;Koyama Tsukasa;Yoneda Hiroshi;Fukumaki Yasuyuki;Shibata Hiroki;Kaneko Sunao;Higuchi Hisashi;Yasui-Furukori Norio;Numachi Yohtaro;Itokawa Masanari;Okazaki Yuji; , American journal of human genetics, 77(6), 937-944, Dec. 2005

  DOIPermalink
• Association between multidrug resistance 1 (MDR1) gene polymorphisms and therapeutic response to bromperidol in schizophrenic patients: a preliminary study., Yasui-Furukori Norio;Saito Manabu;Nakagami Taku;Kaneda Ayako;Tateishi Tomonori;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 30(2), 286-291, Mar. 2006

  DOIPermalink
• Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status., Uno Tsukasa;Shimizu Mikiko;Yasui-Furukori Norio;Sugawara Kazunobu;Tateishi Tomonori, British journal of clinical pharmacology, 61(3), 309-314, Mar. 2006

  DOIPermalink
• Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes., Miura Masatomo;Kagaya Hideaki;Tada Hitoshi;Uno Tsukasa;Yasui-Furukori Norio;Tateishi Tomonori;Suzuki Toshio, British journal of clinical pharmacology, 61(3), 315-320, Mar. 2006

  DOIPermalink
• Digitalis intoxication induced by paroxetine co-administration., Yasui-Furukori Norio;Kaneko Sunao, Lancet (London, England), 367(9512), 788, 04 Mar. 2006

  DOIPermalink
• Rifampicin markedly decreases plasma concentration and hypnotic effect of brotizolam., Ujiie Yukihiro;Fukasawa Takashi;Yasui-Furukori Norio;Suzuki Akihito;Tateishi Tomonori;Otani Koichi, Therapeutic drug monitoring, 28(3), 299-302, Jun. 2006

  DOIPermalink
• Effects of caffeine on the kinetics of fluvoxamine and its major metabolite in plasma after a single oral dose of the drug., Fukasawa Takashi;Yasui-Furukori Norio;Suzuki Akihito;Ishii Genki;Inoue Yoshimasa;Tateishi Tomonori;Otani Koichi, Therapeutic drug monitoring, 28(3), 308-311, Jun. 2006

  DOIPermalink
• Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve., Niioka Takenori;Yasui-Furukori Norio;Uno Tsukasa;Sugawara Kazunobu;Kaneko Sunao;Tateishi Tomonori, Therapeutic drug monitoring, 28(3), 321-325, Jun. 2006

  DOIPermalink
• Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes., Shimizu Mikiko;Uno Tsukasa;Yasui-Furukori Norio;Sugawara Kazunobu;Tateishi Tomonori, European journal of clinical pharmacology, 62(8), 597-603, Aug. 2006

  DOIPermalink
• Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma., Niioka Takenori;Uno Tsukasa;Yasui-Furukori Norio;Takahata Takenori;Shimizu Mikiko;Sugawara Kazunobu;Tateishi Tomonori, Cancer chemotherapy and pharmacology, 59(5), 575-580, Apr. 2007

  DOIPermalink
• Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve., Niioka Takenori;Uno Tsukasa;Yasui-Furukori Norio;Shimizu Mikiko;Sugawara Kazunobu;Tateishi Tomonori, European journal of clinical pharmacology, 62(10), 855-861, Oct. 2006

  DOIPermalink
• Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects., Yasui-Furukori Norio;Saito Manabu;Inoue Yoshimasa;Niioka Takenori;Sato Yasushi;Tsuchimine Shoko;Kaneko Sunao, European journal of clinical pharmacology, 63(1), 51-56, Jan. 2007

  DOIPermalink
• Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations., Uno Tsukasa;Niioka Takenori;Hayakari Makoto;Yasui-Furukori Norio;Sugawara Kazunobu;Tateishi Tomonori, European journal of clinical pharmacology, 63(2), 143-149, Feb. 2007

  DOIPermalink
• Effect of itraconazole on pharmacokinetics of paroxetine: the role of gut transporters., Yasui-Furukori Norio;Saito Manabu;Niioka Takenori;Inoue Yoshimasa;Sato Yasushi;Kaneko Sunao, Therapeutic drug monitoring, 29(1), 45-48, Feb. 2007

  DOIPermalink
• No association between CYP2D6 polymorphisms and personality trait in Japanese., Iwashima Kumiko;Yasui-Furukori Norio;Kaneda Ayako;Saito Manabu;Nakagami Taku;Sato Yasushi;Kaneko Sunao, British journal of clinical pharmacology, 64(1), 96-99, Jul. 2007

  DOIPermalink
• Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese., Yasui-Furukori Norio;Kaneda Ayako;Iwashima Kumiko;Saito Manabu;Nakagami Taku;Tsuchimine Shoko;Kaneko Sunao, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 144B(6), 724-727, 05 Sep. 2007

  DOIPermalink
• Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia., Sakumoto Noboru;Kondo Tsuyoshi;Mihara Kazuo;Suzuki Akihito;Yasui-Furukori Norio, Psychiatry and clinical neurosciences, 61(2), 174-180, Apr. 2007

  DOIPermalink
• Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online., Singh Baljinder;Monteil Arnaud;Bidaud Isabelle;Sugimoto Yoshihisa;Suzuki Toshimitsu;Hamano Shin-ichiro;Oguni Hirokazu;Osawa Makiko;Alonso Maria E;Delgado-Escueta Antonio V;Inoue Yushi;Yasui-Furukori Norio;Kaneko Sunao;Lory Philippe;Yamakawa Kazuhiro, Human mutation, 28(5), 524-525, May 2007

  DOIPermalink
• Different serum concentrations of steady-state valproic acid in two sustained-release formulations., Yasui-Furukori Norio;Saito Manabu;Nakagami Taku;Niioka Takenori;Sato Yasushi;Fujii Akira;Kaneko Sunao, Psychiatry and clinical neurosciences, 61(3), 308-312, Jun. 2007

  DOIPermalink
• Patients with a sodium channel alpha 1 gene mutation show wide phenotypic variation., Osaka Hitoshi;Ogiwara Ikuo;Mazaki Emi;Okamura Nami;Yamashita Sumimasa;Iai Mizue;Yamada Michiko;Kurosawa Kenji;Iwamoto Hiroko;Yasui-Furukori Norio;Kaneko Sunao;Fujiwara Tateki;Inoue Yushi;Yamakawa Kazuhiro, Epilepsy research, 75(1), 46-51, Jun. 2007

  DOIPermalink
• Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients., Yasui-Furukori Norio;Tsuchimine Shoko;Saito Manabu;Nakagami Taku;Sato Yasushi;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 31(6), 1230-1234, 15 Aug. 2007

  DOIPermalink
• Effective electroconvulsive therapy in a 92-year-old dementia patient with psychotic feature., Katagai Hiroshi;Yasui-Furukori Norio;Kikuchi Atsuhiro;Kaneko Sunao, Psychiatry and clinical neurosciences, 61(5), 568-570, Oct. 2007

  DOIPermalink
• New-onset diabetic ketoacidosis in a schizophrenic patient with multiple autoimmune disease during treatment with risperidone., Sato Yasushi;Yasui-Furukori Norio;Kaneko Sunao;Moriyama Takako, Progress in neuro-psychopharmacology & biological psychiatry, 32(2), 577-578, 15 Feb. 2008

  DOIPermalink
• Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers., Niioka Takenori;Miura Masatomo;Uno Tsukasa;Yasui-Furukori Norio;Hayakari Makoto;Tateishi Tomonori;Suzuki Toshio, European journal of clinical pharmacology, 64(5), 503-509, May 2008

  DOIPermalink
• Association between dopamine-related polymorphisms and plasma concentrations of prolactin during risperidone treatment in schizophrenic patients., Yasui-Furukori Norio;Saito Manabu;Tsuchimine Shoko;Nakagami Taku;Sato Yasushi;Sugawara Norio;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 32(6), 1491-1495, 01 Aug. 2008

  DOIPermalink
• Effect of grapefruit juice in relation to human pharmacokinetic study., Uno Tsukasa;Yasui-Furukori Norio, Current clinical pharmacology, 1(2), 157-161, May 2006

  DOIPermalink
• Association between monoamine oxidase A (MAOA) and personality traits in Japanese individuals., Tsuchimine Shoko;Yasui-Furukori Norio;Kaneda Ayako;Saito Manabu;Nakagami Taku;Sato Kimihiko;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 32(8), 1932-1935, 12 Dec. 2008

  DOIPermalink
• Bemegride lengthens seizure duration during electric convulsive therapy in a schizophrenic patient with increased seizure threshold., Katagai Hiroshi;Yasui-Furukori Norio;Kikuchi Atsuhiro;Kaneko Sunao, The journal of ECT, 25(1), 61-63, Mar. 2009

  DOIPermalink
• Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine., Yasui-Furukori Norio;Sato Yasushi;Furukori Hanako;Saito Manabu;Nakagami Taku;Kaneko Sunao, The Journal of clinical psychiatry, 70(1), 95-100, Jan. 2009

  DOIPermalink
• Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder., Sato Yasushi;Yasui-Furukori Norio;Nakagami Taku;Saito Manabu;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 33(3), 416-418, 30 Apr. 2009

  DOIPermalink
• Improvement of tardive dyskinesia following zopiclone treatment., Sugawara Norio;Yasui-Furukori Norio;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 33(4), 727-728, 15 Jun. 2009

  DOIPermalink
• Identification of predictors of post-ictal delirium after electroconvulsive therapy., Kikuchi Atsuhiro;Yasui-Furukori Norio;Fujii Akira;Katagai Hiroshi;Kaneko Sunao, Psychiatry and clinical neurosciences, 63(2), 180-185, Apr. 2009

  DOIPermalink
• Hallucinations associated with modafinil treatment for narcolepsy., Yasui-Furukori Norio;Kusunoki Masato;Kaneko Sunao, Journal of clinical psychopharmacology, 29(4), 408, Aug. 2009

  DOIPermalink
• Minor genetic variants of the dopamine D4 receptor (DRD4) polymorphism are associated with novelty seeking in healthy Japanese subjects., Tsuchimine Shoko;Yasui-Furukori Norio;Kaneda Ayako;Saito Manabu;Sugawara Norio;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 33(7), 1232-1235, 01 Oct. 2009

  DOIPermalink
• Formulations of valproate alter valproate metabolism: a single oral dose kinetic study., Nagai Goyo;Ono Shingo;Yasui-Furukori Norio;Nakamura Akifumi;Mihara Kazuo;Kondo Tsuyoshi, Therapeutic drug monitoring, 31(5), 592-596, Oct. 2009

  DOIPermalink
• Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysis., Mao Mao;Matimba Alice;Scordo Maria G;Gunes Arzu;Zengil Hakan;Yasui-Furukori Norio;Masimirembwa Collen;Dahl Marja-Liisa, Pharmacogenomics, 10(9), 1447-1455, Sep. 2009

  DOIPermalink
• Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics., Yamada Satoshi;Yasui-Furukori Norio;Akamine Yumiko;Kaneko Sunao;Uno Tsukasa, Therapeutic drug monitoring, 31(6), 764-768, Dec. 2009

  DOIPermalink
• Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations., Fujii Akira;Yasui-Furukori Norio;Nakagami Taku;Niioka Takenori;Saito Manabu;Sato Yasushi;Kaneko Sunao, Drug design, development and therapy, 2, 139-144, 06 Feb. 2009

  DOIPermalink
• Sexual dysfunction in Japanese patients with schizophrenia treated with antipsychotics., Fujii Akira;Yasui-Furukori Norio;Sugawara Norio;Sato Yasushi;Nakagami Taku;Saito Manabu;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 34(2), 288-293, 17 Mar. 2010

  DOIPermalink
• No association between polymorphism in tyrosine hydroxylase and personality traits in healthy Japanese subjects., Tsuchimine Shoko;Yasui-Furukori Norio;Kaneda Ayako;Saito Manabu;Nakagami Taku;Sugawara Norio;Kaneko Sunao, Psychiatry and clinical neurosciences, 64(2), 196-198, Apr. 2010

  DOIPermalink
• Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia., Yasui-Furukori Norio;Saito Manabu;Nakagami Taku;Sugawara Norio;Sato Yasushi;Tsuchimine Shoko;Furukori Hanako;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 34(3), 537-540, 16 Apr. 2010

  DOIPermalink
• Prolactin fluctuation over the course of a day during treatments with three atypical antipsychotics in schizophrenic patients., Yasui-Furukori Norio;Furukori Hanako;Sugawara Norio;Tsuchimine Shoko;Fujii Akira;Inoue Yoshimasa;Kaneko Sunao, Human psychopharmacology, 25(3), 236-242, Apr. 2010

  DOIPermalink
• Characteristics of the tree-drawing test in chronic schizophrenia., Kaneda Ayako;Yasui-Furukori Norio;Saito Manabu;Sugawara Norio;Nakagami Taku;Furukori Hanako;Kaneko Sunao, Psychiatry and clinical neurosciences, 64(2), 141-148, Apr. 2010

  DOIPermalink
• Effect of dose timing in relation to food intake on systemic exposure to blonanserin., Saruwatari Junji;Yasui-Furukori Norio;Inoue Yoshimasa;Kaneko Sunao, European journal of clinical pharmacology, 66(9), 899-902, Sep. 2010

  DOIPermalink
• [Clinical pharmacogenetics in the treatment of schizophrenia]., Furukori Norio, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 30(2), 65-69, Apr. 2010

  Permalink
• Comparison of ankle-brachial pressure index and pulse wave velocity as markers of cognitive function in a community-dwelling population., Sugawara Norio;Yasui-Furukori Norio;Umeda Takashi;Kaneda Ayako;Sato Yasushi;Takahashi Ippei;Matsuzaka Masashi;Danjo Kazuma;Nakaji Shigeyuki;Kaneko Sunao, BMC psychiatry, 10, 46, 10 Jun. 2010

  DOIPermalink
• Clock drawing performance in a community-dwelling population: Normative data for Japanese subjects., Sugawara Norio;Yasui-Furukori Norio;Umeda Takashi;Sato Yasushi;Kaneda Ayako;Tsuchimine Shoko;Saito Manabu;Nakaji Shigeyuki;Kaneko Sunao, Aging & mental health, 14(5), 587-592, Jul. 2010

  DOIPermalink
• Ankle brachial pressure index as a marker of apathy in a community-dwelling population., Sugawara Norio;Yasui-Furukori Norio;Umeda Takashi;Kaneda Ayako;Sato Yasushi;Takahashi Ippei;Matsuzaka Masashi;Danjo Kazuma;Nakaji Shigeyuki;Kaneko Sunao, International journal of geriatric psychiatry, 26(4), 409-414, Apr. 2011

  DOIPermalink
• Comparing the influences of age and disease on distortion in the clock drawing test in Japanese patients with schizophrenia., Kaneda Ayako;Yasui-Furukori Norio;Umeda Takashi;Sugawara Norio;Tsuchimine Shoko;Saito Manabu;Sato Yasushi;Furukori Hanako;Takahashi Ippei;Nakaji Shigeyuki;Kaneko Sunao, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 18(10), 908-916, Oct. 2010

  DOIPermalink
• Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia., Yasui-Furukori Norio;Furukori Hanako;Sugawara Norio;Fujii Akira;Kaneko Sunao, Journal of clinical psychopharmacology, 30(5), 596-599, Oct. 2010

  DOIPermalink
• Influence of HTR2A polymorphisms and parental rearing on personality traits in healthy Japanese subjects., Nakamura Yukako;Ito Yoshihito;Aleksic Branko;Kushima Itaru;Yasui-Furukori Norio;Inada Toshiya;Ono Yutaka;Ozaki Norio, Journal of human genetics, 55(12), 838-841, Dec. 2010

  DOIPermalink
• Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers., Akamine Yumiko;Miura Masatomo;Sunagawa Satoko;Kagaya Hideaki;Yasui-Furukori Norio;Uno Tsukasa, Xenobiotica; the fate of foreign compounds in biological systems, 40(11), 782-789, Nov. 2010

  DOIPermalink
• Prevalence of metabolic syndrome among patients with schizophrenia in Japan., Sugawara Norio;Yasui-Furukori Norio;Sato Yasushi;Umeda Takashi;Kishida Ikuko;Yamashita Hakuei;Saito Manabu;Furukori Hanako;Nakagami Taku;Hatakeyama Mitsunori;Nakaji Shigeyuki;Kaneko Sunao, Schizophrenia research, 123(2-3), 244-250, Nov. 2010

  DOIPermalink
• A crossover study on the glucose metabolism between treatment with olanzapine and risperidone in schizophrenic patients., Sato Yasushi;Yasui-Furukori Norio;Furukori Hanako;Saito Manabu;Nakagami Taku;Kaneko Sunao, Experimental and clinical psychopharmacology, 18(5), 445-450, Oct. 2010

  DOIPermalink
• A sensitive column-switching HPLC method for aripiprazole and dehydroaripiprazole and its application to human pharmacokinetic studies., Akamine Yumiko;Yasui-Furukori Norio;Kojima Midori;Inoue Yoshimasa;Uno Tsukasa, Journal of separation science, 33(21), 3292-3298, Nov. 2010

  DOIPermalink
• The effect of smoking status on the plasma concentration of prolactin already elevated by risperidone treatment in schizophrenia patients., Ohta Chikako;Yasui-Furukori Norio;Furukori Hanako;Tsuchimine Shoko;Saito Manabu;Nakagami Taku;Yoshizawa Kaori;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 35(2), 573-576, 30 Mar. 2011

  DOIPermalink
• Assessment of the Center for Epidemiological Studies Depression Scale factor structure among middle-aged workers in Japan., Sugawara Norio;Yasui-Furukori Norio;Sasaki Giro;Umeda Takashi;Takahashi Ippei;Danjo Kazuma;Matsuzaka Masashi;Kaneko Sunao;Nakaji Shigeyuki, Psychiatry and clinical neurosciences, 65(1), 109-111, Feb. 2011

  DOIPermalink
• Hallucination induced by paroxetine discontinuation in patients with major depressive disorders., Yasui-Furukori Norio;Kaneko Sunao, Psychiatry and clinical neurosciences, 65(4), 384-385, Jun. 2011

  DOIPermalink
• Effect of adjunctive treatment with aripiprazole to atypical antipsychotics on cognitive function in schizophrenia patients., Yasui-Furukori Norio;Kaneda Ayako;Sugawara Norio;Tomita Tetsu;Kaneko Sunao, Journal of psychopharmacology (Oxford, England), 26(6), 806-812, Jun. 2012

  DOIPermalink
• Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder., Yasui-Furukori Norio;Tsuchimine Shoko;Nakagami Taku;Fujii Akira;Sato Yasushi;Tomita Tetsu;Yoshizawa Kaori;Inoue Yoshimasa;Kaneko Sunao, Human psychopharmacology, 26(3), 194-200, Apr. 2011

  DOIPermalink
• Chiral assay of omeprazole and metabolites and its application to a pharmacokinetics related to CYP2C19 genotypes., Shiohira Hideo;Yasui-Furukori Norio;Tateishi Tomonori;Uno Tsukasa, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 879(24), 2465-2470, 15 Aug. 2011

  DOIPermalink
• The influence of personality factors on paroxetine response time in patients with major depression., Kaneda Ayako;Yasui-Furukori Norio;Nakagami Taku;Sato Yasushi;Kaneko Sunao, Journal of affective disorders, 135(1-3), 321-325, Dec. 2011

  DOIPermalink
• Cognitive function among hemodialysis patients in Japan., Odagiri Gen;Sugawara Norio;Kikuchi Atsuhiro;Takahashi Ippei;Umeda Takashi;Saitoh Hisao;Yasui-Furukori Norio;Kaneko Sunao, Annals of general psychiatry, 10, 20, 25 Aug. 2011

  DOIPermalink
• Comparing the influence of dopamine D₂ polymorphisms and plasma drug concentrations on the clinical response to risperidone., Yasui-Furukori Norio;Tsuchimine Shoko;Saito Manabu;Nakagami Taku;Sugawara Norio;Fujii Akira;Kaneko Sunao, Journal of clinical psychopharmacology, 31(5), 633-637, Oct. 2011

  DOIPermalink
• Depression increases the length of hospitalization for patients undergoing thoracic surgery: a preliminary study., Kitagawa Rieko;Yasui-Furukori Norio;Tsushima Takao;Kaneko Sunao;Fukuda Ikuo, Psychosomatics, 52(5), 428-432

  DOIPermalink
• Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia., Sugawara Norio;Yasui-Furukori Norio;Sato Yasushi;Kishida Ikuko;Yamashita Hakuei;Saito Manabu;Furukori Hanako;Nakagami Taku;Hatakeyama Mitsunori;Kaneko Sunao, Annals of general psychiatry, 10, 21, 12 Sep. 2011

  DOIPermalink
• Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers., Akamine Yumiko;Miura Masatomo;Yasui-Furukori Norio;Kojima Midori;Uno Tsukasa, British journal of clinical pharmacology, 73(3), 478-481, Mar. 2012

  DOIPermalink
• Hearing impairment and cognitive function among a community-dwelling population in Japan., Sugawara Norio;Sasaki Akira;Yasui-Furukori Norio;Kakehata Seiji;Umeda Takashi;Namba Atsushi;Nakaji Shigeyuki;Shinkawa Hideichi;Kaneko Sunao, Annals of general psychiatry, 10(1), 27, 01 Oct. 2011

  DOIPermalink
• Relationships between suicidal ideation and the dimensions of depressive symptoms among middle-aged population in Japan., Sugawara Norio;Yasui-Furukori Norio;Sasaki Giro;Umeda Takashi;Takahashi Ippei;Danjo Kazuma;Matsuzaka Masashi;Kaneko Sunao;Nakaji Shigeyuki, Journal of affective disorders, 136(3), 819-823, Feb. 2012

  DOIPermalink
• Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders., Yasui-Furukori Norio;Nakagami Taku;Kaneda Ayako;Inoue Yoshimasa;Suzuki Akihito;Otani Koichi;Kaneko Sunao, Human psychopharmacology, 26(8), 602-608, Dec. 2011

  DOIPermalink
• The efficacy of low-dose aripiprazole treatment for trichotillomania., Yasui-Furukori Norio;Kaneko Sunao, Clinical neuropharmacology, 34(6), 258-259

  DOIPermalink
• No association between bone mass and prolactin levels among patients with schizophrenia., Sugawara Norio;Yasui-Furukori Norio;Fujii Akira;Saito Manabu;Sato Yasushi;Nakagami Taku;Tsuchimine Shoko;Kaneko Sunao, Human psychopharmacology, 26(8), 596-601, Dec. 2011

  DOIPermalink
• Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferases., Saruwatari Junji;Deguchi Mariko;Yoshimori Yuki;Noai Madoka;Yoshida Shiho;Ogusu Naoki;Oniki Kentaro;Yoshida Shuichi;Yasui-Furukori Norio;Kaneko Sunao;Ishitsu Takateru;Nakagawa Kazuko, Epilepsy research, 99(1-2), 183-186, Mar. 2012

  DOIPermalink
• The association between sunshine duration and paroxetine response time in patients with major depressive disorder., Tomita Tetsu;Yasui-Furukori Norio;Nakagami Taku;Kaneda Ayako;Kaneko Sunao, Journal of affective disorders, 136(3), 1067-1071, Feb. 2012

  DOIPermalink
• Paroxetine-associated hypereosinophilia may clinically resemble a panic attack., Yasui-Furukori Norio;Sato Yasushi;Kato Hiroyuki;Kaneko Sunao, Clinical neuropharmacology, 35(1), 47-48

  DOIPermalink
• No association between hormonal abnormality and sexual dysfunction in Japanese schizophrenia patients treated with antipsychotics., Yasui-Furukori Norio;Fujii Akira;Sugawara Norio;Tsuchimine Shoko;Saito Manabu;Hashimoto Kojiro;Kaneko Sunao, Human psychopharmacology, 27(1), 82-89, Jan. 2012

  DOIPermalink
• [Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia]., Kaneda Yasuhiro;Ueoka Yoshinori;Sumiyoshi Tomiki;Yasui-Furukori Norio;Ito Toru;Higuchi Yuko;Suzuki Michio;Ohmori Tetsuro, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 31(5-6), 259-262, Nov. 2011

  Permalink
• Effect of age and disease on bone mass in Japanese patients with schizophrenia., Sugawara Norio;Yasui-Furukori Norio;Umeda Takashi;Tsuchimine Shoko;Fujii Akira;Sato Yasushi;Saito Manabu;Furukori Hanako;Danjo Kazuma;Matsuzaka Masashi;Takahashi Ippei;Kaneko Sunao, Annals of general psychiatry, 11, 5, 20 Feb. 2012

  DOIPermalink
• Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers., Saruwatari Junji;Yasui-Furukori Norio;Niioka Takenori;Akamine Yumiko;Takashima Ayaka;Kaneko Sunao;Uno Tsukasa, Journal of clinical psychopharmacology, 32(2), 195-199, Apr. 2012

  DOIPermalink
• Association between the dopamine D2 receptor (DRD2) polymorphism and the personality traits of healthy Japanese participants., Tsuchimine Shoko;Yasui-Furukori Norio;Sasaki Kunihiro;Kaneda Ayako;Sugawara Norio;Yoshida Shuichi;Kaneko Sunao, Progress in neuro-psychopharmacology & biological psychiatry, 38(2), 190-193, 07 Aug. 2012

  DOIPermalink
• Hydroxylation of R(+)- and S(-)-omeprazole after racemic dosing are different among the CYP2C19 genotypes., Shiohira Hideo;Yasui-Furukori Norio;Yamada Satoshi;Tateishi Tomonori;Akamine Yumiko;Uno Tsukasa, Pharmaceutical research, 29(8), 2310-2316, Aug. 2012

  DOIPermalink
• Body composition in patients with schizophrenia: Comparison with healthy controls., Sugawara Norio;Yasui-Furukori Norio;Tsuchimine Shoko;Fujii Akira;Sato Yasushi;Saito Manabu;Matsuzaka Masashi;Takahashi Ippei;Kaneko Sunao, Annals of general psychiatry, 11(1), 11, 03 May 2012

  DOIPermalink
• Update on the development of lurasidone as a treatment for patients with acute schizophrenia., Yasui-Furukori Norio, Drug design, development and therapy, 6, 107-115, 2012

  DOIPermalink
• Coping behaviors in relation to depressive symptoms and suicidal ideation among middle-aged workers in Japan., Sugawara Norio;Yasui-Furukori Norio;Sasaki Giro;Tanaka Osamu;Umeda Takashi;Takahashi Ippei;Iwane Kaori;Matsuzaka Masashi;Kaneko Sunao;Nakaji Shigeyuki, Journal of affective disorders, 142(1-3), 264-268, 15 Dec. 2012

  DOIPermalink
• DRD3, but not BDNF, genotype affects treatment response to paroxetine in major depressive disorder: a preliminary study., Tsuchimine Shoko;Yasui-Furukori Norio;Nakagami Taku;Sato Yasushi;Kaneko Sunao, Journal of clinical psychopharmacology, 32(5), 724-726, Oct. 2012

  DOIPermalink
• Factor structure of the Liebowitz Social Anxiety Scale in community-dwelling subjects in Japan., Sugawara Norio;Yasui-Furukori Norio;Kaneda Ayako;Sato Yasushi;Tsuchimine Shoko;Fujii Akira;Danjo Kazuma;Takahashi Ippei;Matsuzaka Masashi;Kaneko Sunao, Psychiatry and clinical neurosciences, 66(6), 525-528, Oct. 2012

  DOIPermalink
• No association between dietary patterns and depressive symptoms among a community-dwelling population in Japan., Sugawara Norio;Yasui-Furukori Norio;Tsuchimine Shoko;Kaneda Ayako;Tsuruga Koji;Iwane Kaori;Okubo Noriyuki;Takahashi Ippei;Kaneko Sunao, Annals of general psychiatry, 11(1), 24, 24 Sep. 2012

  DOIPermalink
• Psychotropic drug-drug interactions involving P-glycoprotein., Akamine Yumiko;Yasui-Furukori Norio;Ieiri Ichiro;Uno Tsukasa, CNS drugs, 26(11), 959-973, Nov. 2012

  DOIPermalink
• Effect of coadministration of single and multiple doses of rifampicin on the pharmacokinetics of fexofenadine enantiomers in healthy subjects., Kusuhara Hiroyuki;Miura Masatomo;Yasui-Furukori Norio;Yoshida Kenta;Akamine Yumiko;Yokochi Miyu;Fukizawa Shinya;Ikejiri Kazuaki;Kanamitsu Kayoko;Uno Tsukasa;Sugiyama Yuichi, Drug metabolism and disposition: the biological fate of chemicals, 41(1), 206-213, Jan. 2013

  DOIPermalink
• The CLOCK C3111T polymorphism is associated with reward dependence in healthy Japanese subjects., Tsuchimine Shoko;Yasui-Furukori Norio;Kaneda Ayako;Kaneko Sunao, Neuropsychobiology, 67(1), 1-5, 2013

  DOIPermalink
• Gender differences in factors associated with suicidal ideation and depressive symptoms among middle-aged workers in Japan., Sugawara Norio;Yasui-Furukori Norio;Sasaki Giro;Tanaka Osamu;Umeda Takashi;Takahashi Ippei;Danjo Kazuma;Matsuzaka Masashi;Kaneko Sunao;Nakaji Shigeyuki, Industrial health, 51(2), 202-213, 2013

  DOIPermalink
• The (R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers., Yamada Satoshi;Shiohira Hideo;Yasui-Furukori Norio;Tateishi Tomonori;Akamine Yumiko;Uno Tsukasa, European journal of clinical pharmacology, 69(7), 1423-1428, Jul. 2013

  DOIPermalink
• Interaction between paliperidone extended release and TS-1(®), an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient., Yasui-Furukori Norio;Hashimoto Kojiro;Kubo Kazutoshi;Tomita Tetsu, Neuropsychiatric disease and treatment, 9, 317-320, 2013

  DOIPermalink
• Body mass index and quality of life among outpatients with schizophrenia in Japan., Sugawara Norio;Yasui-Furukori Norio;Sato Yasushi;Saito Manabu;Furukori Hanako;Nakagami Taku;Kudo Shuhei;Kaneko Sunao, BMC psychiatry, 13, 108, 09 Apr. 2013

  DOIPermalink
• Worsened hypertension control induced by aripiprazole., Yasui-Furukori Norio;Fujii Akira, Neuropsychiatric disease and treatment, 9, 505-507, 2013

  DOIPermalink
• No association between a polymorphism in the serotonin receptor 2B (HTR2B) gene and personality traits in healthy Japanese subjects., Tsuchimine Shoko;Taniguchi Takeshi;Sugawara Norio;Kaneda Ayako;Yasui-Furukori Norio, Neuropsychobiology, 68(1), 59-62, 2013

  DOIPermalink
• Neuroleptic malignant syndrome induced by lamotrigine., Ishioka Masamichi;Yasui-Furukori Norio;Hashimoto Kojiro;Sugawara Norio, Clinical neuropharmacology, 36(4), 131-132

  DOIPermalink
• Cognitive function and number of teeth in a community-dwelling population in Japan., Saito Yuki;Sugawara Norio;Yasui-Furukori Norio;Takahashi Ippei;Nakaji Shigeyuki;Kimura Hiroto, Annals of general psychiatry, 12(1), 20, 24 Jun. 2013

  DOIPermalink
• Association between plasma brain-derived neurotrophic factor levels and personality traits in healthy Japanese subjects., Yasui-Furukori Norio;Tsuchimine Shoko;Kaneda Ayako;Sugawara Norio;Ishioka Masamichi;Kaneko Sunao, Psychiatry research, 210(1), 220-223, 30 Nov. 2013

  DOIPermalink
• Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia., Kaneda Ayako;Katagai Takeshi;Yasui-Furukori Norio, Neuropsychiatric disease and treatment, 9, 1203-1208, 2013

  DOIPermalink
• Visual hallucinations during duloxetine treatment in a patient with major depressive disorder., Tomita Tetsu;Yasui-Furukori Norio;Kaneko Sunao, Clinical neuropharmacology, 36(5), 175-176

  DOIPermalink
• Interaction between paliperidone and carbamazepine., Yasui-Furukori Norio;Kubo Kazutoshi;Ishioka Masamichi;Tsuchimine Shoko;Inoue Yoshimasa, Therapeutic drug monitoring, 35(5), 649-652, Oct. 2013

  DOIPermalink
• Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia., Saruwatari Junji;Yasui-Furukori Norio;Kamihashi Ryoko;Yoshimori Yuki;Oniki Kentaro;Tsuchimine Shoko;Noai Madoka;Sato Yasushi;Nakagami Taku;Sugawara Norio;Saito Manabu;Fujii Akira;Kajiwara Ayami;Mihara Shuichi;Ogata Yasuhiro;Kaneko Sunao;Nakagawa Kazuko, Neuropsychiatric disease and treatment, 9, 1683-1698, 2013

  DOIPermalink
• Lithium in tap water and suicide mortality in Japan., Sugawara Norio;Yasui-Furukori Norio;Ishii Nobuyoshi;Iwata Noboru;Terao Takeshi, International journal of environmental research and public health, 10(11), 6044-6048, 12 Nov. 2013

  DOIPermalink
• Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals., Tsuchimine Shoko;Yasui-Furukori Norio;Kaneda Ayako;Kaneko Sunao, PloS one, 8(11), e76763, 2013

  DOIPermalink
• Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in japanese patients with epilepsy., Saruwatari Junji;Ogusu Naoki;Shimomasuda Masatsugu;Nakashima Hiroo;Seo Takayuki;Tanikawa Koji;Tsuda Yoshiyuki;Nishimura Miki;Nagata Rie;Yasui-Furukori Norio;Kaneko Sunao;Ishitsu Takateru;Nakagawa Kazuko, Therapeutic drug monitoring, 36(3), 302-309, Jun. 2014

  DOIPermalink
• Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction., Saruwatari Junji;Yoshida Shiho;Tsuda Yoshiyuki;Okada Yusuke;Ogusu Naoki;Yoshida Kousuke;Oniki Kentaro;Yasui-Furukori Norio;Kaneko Sunao;Ishitsu Takateru;Nakagawa Kazuko, Pharmacogenetics and genomics, 24(3), 162-171, Mar. 2014

  DOIPermalink
• Relationships between vascular endothelial growth factor levels and temperament and character inventory traits in healthy Japanese subjects., Tomita Tetsu;Yasui-Furukori Norio;Tsuchimine Shoko;Kaneda Ayako;Kaneko Sunao, Neuropsychobiology, 69(1), 1-5, 2014

  DOIPermalink
• Development of individualized medicine for epilepsy based on genetic information., Kaneko Sunao;Yoshida Shuichi;Kanai Kazuaki;Yasui-Furukori Norio;Iwasa Hiroto, Expert review of clinical pharmacology, 1(5), 661-681, Sep. 2008

  DOIPermalink
• Psychiatrists' attitudes toward metabolic adverse events in patients with schizophrenia., Sugawara Norio;Yasui-Furukori Norio;Yamazaki Manabu;Shimoda Kazutaka;Mori Takao;Sugai Takuro;Suzuki Yutaro;Someya Toshiyuki, PloS one, 9(1), e86826, 2014

  DOIPermalink
• Preanalysis storage conditions influence the measurement of brain-derived neurotrophic factor levels in peripheral blood., Tsuchimine Shoko;Sugawara Norio;Ishioka Masamichi;Yasui-Furukori Norio, Neuropsychobiology, 69(2), 83-88, 2014

  DOIPermalink
• Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine., Tsuda Yoshiyuki;Saruwatari Junji;Yasui-Furukori Norio, BMJ open, 4(3), e004216, 04 Mar. 2014

  DOIPermalink
• Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan., Sugawara Norio;Yasui-Furukori Norio;Tomita Tetsu;Furukori Hanako;Kubo Kazutoshi;Nakagami Taku;Kaneko Sunao, Neuropsychiatric disease and treatment, 10, 427-432, 2014

  DOIPermalink
• Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response., Tomita Tetsu;Yasui-Furukori Norio;Norio Yasui-Furukori;Sato Yasushi;Nakagami Taku;Tsuchimine Shoko;Kaneda Ayako;Kaneko Sunao, Neuropsychiatric disease and treatment, 10, 599-606, 2014

  DOIPermalink
• The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder., Tomita Tetsu;Yasui-Furukori Norio;Nakagami Taku;Tsuchimine Shoko;Ishioka Masamichi;Kaneda Ayako;Sugawara Norio;Kaneko Sunao, PloS one, 9(5), e98099, 2014

  DOIPermalink
• Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders., Saruwatari Junji;Nakashima Hiroo;Tsuchimine Shoko;Nishimura Miki;Ogusu Naoki;Yasui-Furukori Norio, Pharmacogenomics and personalized medicine, 7, 121-127, 2014

  DOIPermalink
• An investigation of temperament and character inventory items for predicting the response to paroxetine treatment in patients with major depressive disorder., Tomita Tetsu;Ishioka Masamichi;Kaneda Ayako;Sugawara Norio;Nakagami Taku;Nakamura Kazuhiko;Yasui-Furukori Norio, Journal of affective disorders, 165, 109-113, Aug. 2014

  DOIPermalink
• Second-generation antipsychotics and bone turnover in schizophrenia., Okita Kyoji;Kanahara Nobuhisa;Nishimura Motoi;Yoshida Toshihiko;Yasui-Furukori Norio;Niitsu Tomihisa;Yoshida Taisuke;Ishikawa Masatomo;Kimura Hiroshi;Nomura Fumio;Iyo Masaomi, Schizophrenia research, 157(1-3), 137-141, Aug. 2014

  DOIPermalink
• Sex-specific effects of subjective memory complaints with respect to cognitive impairment or depressive symptoms., Tomita Tetsu;Sugawara Norio;Kaneda Ayako;Okubo Noriyuki;Iwane Kaori;Takahashi Ippei;Kaneko Sunao;Yasui-Furukori Norio, Psychiatry and clinical neurosciences, 68(3), 176-181, Mar. 2014

  DOIPermalink
• Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers., Akamine Yumiko;Miura Masatomo;Komori Hisakazu;Saito Shun;Kusuhara Hiroyuki;Tamai Ikumi;Ieiri Ichiro;Uno Tsukasa;Yasui-Furukori Norio, European journal of clinical pharmacology, 70(9), 1087-1095, Sep. 2014

  DOIPermalink
• Dietary patterns are associated with obesity in Japanese patients with schizophrenia., Sugawara Norio;Yasui-Furukori Norio;Sato Yasushi;Saito Manabu;Furukori Hanako;Nakagami Taku;Ishioka Masamichi;Kaneko Sunao, BMC psychiatry, 14, 184, 20 Jun. 2014

  DOIPermalink
• Therapeutic reference range for plasma concentrations of paroxetine in patients with major depressive disorders., Tomita Tetsu;Yasui-Furukori Norio;Nakagami Taku;Tsuchimine Shoko;Ishioka Masamichi;Kaneda Ayako;Nakamura Kazuhiko;Kaneko Sunao, Therapeutic drug monitoring, 36(4), 480-485, Aug. 2014

  DOIPermalink
• The effects of electroconvulsive therapy on tardive dystonia or dyskinesia induced by psychotropic medication: a retrospective study., Yasui-Furukori Norio;Kikuchi Atsuhiro;Katagai Hiroshi;Kaneko Sunao, Neuropsychiatric disease and treatment, 10, 1209-1212, 2014

  DOIPermalink
• Adrenal Cushing's syndrome may resemble eating disorders., Hatakeyama Makiko;Nakagami Taku;Yasui-Furukori Norio, General hospital psychiatry, 36(6), 760.e9-760.10, 28 Jun. 2014

  DOIPermalink
• Comorbidity of Stevens-Johnson syndrome and neutropenia associated with lamotrigine: a case report., Yasui-Furukori Norio;Hashimoto Kojiro;Tsuruga Koji;Nakamura Kazuhiko, General hospital psychiatry, 36(6), 761.e9-761.11, 27 Jul. 2014

  DOIPermalink
• The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study., Hashimoto Kojiro;Sugawara Norio;Ishioka Masamichi;Nakamura Kazuhiko;Yasui-Furukori Norio, Neuropsychiatric disease and treatment, 10, 1571-1576, 2014

  DOIPermalink
• A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan., Tsuruga Koji;Sugawara Norio;Yasui-Furukori Norio;Takahashi Ippei;Tsuchimine Shoko;Kaneda Ayako;Nakaji Shigeyuki;Nakamura Kazuhiko, Neuropsychiatric disease and treatment, 10, 1621-1627, 2014

  DOIPermalink
• The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects - a preliminary study., Ishioka Masamichi;Sugawara Norio;Kaneda Ayako;Okubo Noriyuki;Iwane Kaori;Takahashi Ippei;Yasui-Furukori Norio, Neuropsychiatric disease and treatment, 10, 1721-1725, 2014

  DOIPermalink
• Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder., Aoki Akiko;Ishiguro Shin;Watanabe Takashi;Ueda Mikito;Hayashi Yuki;Akiyama Kazufumi;Kato Kazuko;Inoue Yoshimasa;Tsuchimine Shoko;Yasui-Furukori Norio;Shimoda Kazutaka, Neuropsychiatric disease and treatment, 10, 1793-1798, 2014

  DOIPermalink
• Parental bonding and attitudes toward suicide among medical college students in Japan., Hashimoto Kojiro;Sugawara Norio;Tanaka Osamu;Nakamura Kazuhiko;Yasui-Furukori Norio, Neuropsychiatric disease and treatment, 10, 2015-2020, 2014

  DOIPermalink
• Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysis., Ogusu Naoki;Saruwatari Junji;Nakashima Hiroo;Noai Madoka;Nishimura Miki;Deguchi Mariko;Oniki Kentaro;Yasui-Furukori Norio;Kaneko Sunao;Ishitsu Takateru;Nakagaswa Kazuko, PloS one, 9(11), e111066, 2014

  DOIPermalink
• Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsy., Tanamachi Yukiko;Saruwatari Junji;Noai Madoka;Kamihashi Ryoko;Soraoka Hiromi;Yoshimori Yuki;Ogusu Naoki;Oniki Kentaro;Yasui-Furukori Norio;Ishitsu Takateru;Nakagawa Kazuko, Neuropsychiatric disease and treatment, 11, 1007-1014, 2015

  DOIPermalink
• Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV., Tomita Tetsu;Yasui-Furukori Norio;Sugawara Norio;Ogasawara Kohei;Katagai Koki;Saito Hisao;Sawada Kaori;Takahashi Ippei;Nakamura Kazuhiko, Neuropsychiatric disease and treatment, 12, 2503-2508, 2016

  DOIPermalink
• Work-family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan., Sugawara Norio;Danjo Kazuma;Furukori Hanako;Sato Yasushi;Tomita Tetsu;Fujii Akira;Nakagami Taku;Kitaoka Kazuyo;Yasui-Furukori Norio, Neuropsychiatric disease and treatment, 13, 779-784, 2017

  DOIPermalink
• Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry., Ogasawara Kazuyoshi;Numata Shusuke;Hasegawa Naomi;Nakataki Masahito;Makinodan Manabu;Ohi Kazutaka;Takeshima Masahiro;Tsuboi Takashi;Hashimoto Naoki;Onitsuka Toshiaki;Muraoka Hiroyuki;Hori Hikaru;Ichihashi Kayo;Inagaki Takahiko;Yasui-Furukori Norio;Hishimoto Akitoyo;Sugiyama Nobuhiro;Fukumoto Kentaro;Nagasawa Tatsuya;Matsumoto Junya;Takaesu Yoshikazu;Furihata Ryuji;Nemoto Kiyotaka;Nakamura Toshinori;Usami Masahide;Miura Kenichiro;Fujimoto Michiko;Tagata Hiromi;Yamada Hisashi;Komatsu Hiroshi;Ochi Shinichiro;Atake Kiyokazu;Katsumoto Eiichi;Kido Mikio;Kishimoto Taishiro;Suwa Taro;Yamamura Satoshi;Iga Jun-Ichi;Iida Hitoshi;Inada Ken;Watanabe Koichiro;Hashimoto Ryota, Neuropsychopharmacology reports, 10 Mar. 2022

  DOIPermalink
• Relationship Between Cognitive Functions and Decision-Making Capacity in Older Institutionalized Patients with Schizophrenia: A Preliminary Study., Sugawara Norio;Yasui-Furukori Norio;Yamada Sonoko;Aoki Mei;Takeuchi Yoshitaka;Miyazaki Kensuke;Shimoda Kazutaka, Neuropsychiatric disease and treatment, 18, 891-897, 15 Apr. 2022

  DOIPermalink
• Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics., Hori Hikaru;Yasui-Furukori Norio;Hasegawa Naomi;Iga Jun-Ichi;Ochi Shinichiro;Ichihashi Kayo;Furihata Ryuji;Kyo Yoshitaka;Takaesu Yoshikazu;Tsuboi Takashi;Kodaka Fumitoshi;Onitsuka Toshiaki;Okada Tsuyoshi;Murata Atsunobu;Kashiwagi Hiroko;Iida Hitoshi;Hashimoto Naoki;Ohi Kazutaka;Yamada Hisashi;Ogasawara Kazuyoshi;Yasuda Yuka;Muraoka Hiroyuki;Usami Masahide;Numata Shusuke;Takeshima Masahiro;Yamagata Hirotaka;Nagasawa Tatsuya;Tagata Hiromi;Makinodan Manabu;Kido Mikio;Katsumoto Eiichi;Komatsu Hiroshi;Matsumoto Junya;Kubota Chika;Miura Kenichiro;Hishimoto Akitoyo;Watanabe Koichiro;Inada Ken;Kawasaki Hiroaki;Hashimoto Ryota, Frontiers in psychiatry, 13, 823826, 17 May 2022

  DOI
• Characteristics of the treatments for each severity of major depressive disorder: A real-world multi-site study., Muraoka Hiroyuki;Kodaka Fumitoshi;Hasegawa Naomi;Yasui-Furukori Norio;Fukumoto Kentaro;Kashiwagi Hiroko;Tagata Hiromi;Hori Hikaru;Atake Kiyokazu;Iida Hitoshi;Ichihashi Kayo;Furihata Ryuji;Tsuboi Takashi;Takeshima Masahiro;Komatsu Hiroshi;Kubota Chika;Ochi Shinichiro;Takaesu Yoshikazu;Usami Masahide;Nagasawa Tatsuya;Makinodan Manabu;Nakamura Toshinori;Kido Mikio;Ueda Ikki;Yamagata Hirotaka;Onitsuka Toshiaki;Asami Takeshi;Hishimoto Akitoyo;Ogasawara Kazuyoshi;Katsumoto Eiichi;Miura Kenichiro;Matsumoto Junya;Ohi Kazutaka;Yamada Hisashi;Watanabe Koichiro;Inada Ken;Nishimura Katsuji;Hashimoto Ryota, Asian journal of psychiatry, 74, 103174, 18 May 2022

  DOI
• Determinants of three-year clinical outcomes in real-world outpatients with bipolar disorder: The multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics (MUSUBI)., Sugawara Norio;Adachi Naoto;Kubota Yukihisa;Watanabe Yoichiro;Miki Kazuhira;Azekawa Takaharu;Edagawa Koji;Katsumoto Eiichi;Hongo Seiji;Goto Eiichiro;Ueda Hitoshi;Kato Masaki;Yoshimura Reiji;Nakagawa Atsuo;Kikuchi Toshiaki;Tsuboi Takashi;Watanabe Koichiro;Shimoda Kazutaka;Yasui-Furukori Norio, Journal of psychiatric research, 151, 683-692, 24 May 2022

  DOI
• Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study., Ochi Shinichiro;Tagata Hiromi;Hasegawa Naomi;Yasui-Furukori Norio;Iga Jun-Ichi;Kashiwagi Hiroko;Kodaka Fumitoshi;Komatsu Hiroshi;Tsuboi Takashi;Tokutani Akira;Numata Shusuke;Ichihashi Kayo;Onitsuka Toshiaki;Muraoka Hiroyuki;Iida Hitoshi;Ohi Kazutaka;Atake Kiyokazu;Kishimoto Taishiro;Hori Hikaru;Takaesu Yoshikazu;Takeshima Masahiro;Usami Masahide;Makinodan Manabu;Hashimoto Naoki;Fujimoto Michiko;Furihata Ryuji;Nagasawa Tatsuya;Yamada Hisashi;Matsumoto Junya;Miura Kenichiro;Kido Mikio;Hishimoto Akitoyo;Ueno Shu-Ichi;Watanabe Koichiro;Inada Ken;Hashimoto Ryota, The international journal of neuropsychopharmacology, 25(10), 818-826, 25 Oct. 2022

  DOI
• Asymptomatic syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following duloxetine treatment for pain with depression: Two case reports., Sato Aoi;Yasui-Furukori Norio;Oda Yumiko;Yang Misa;Suzuki Yudai;Shinozaki Masataka;Shimizu Taro;Shimoda Kazutaka, Neuropsychopharmacology reports, 42(3), 387-390, 22 Jun. 2022

  DOI
• A case of mood disorder with severe side effects of antidepressants in association with resistance to thyroid hormone beta with a THRB mutation., Komahashi-Sasaki Hazuki;Yasui-Furukori Norio;Maehara Ryo;Hasegawa Chie;Shimoda Kazutaka, Neuropsychopharmacology reports, 42(3), 391-394, 24 Jun. 2022

  DOI
• New Insight Concerning Therapeutic Drug Monitoring-The Importance of the Concept of Psychonephrology., Hashimoto Mai;Maeda Hitoshi;Oniki Kentaro;Yasui-Furukori Norio;Watanabe Hiroshi;Saruwatari Junji;Kadowaki Daisuke, Biological & pharmaceutical bulletin, 45(7), 834-842, 2022

  DOI
• Association Between Psychotropic Medications and Cases of Severe Falls From Hospital Patient Safety Reports., Sato Yoshiteru;Sugawara Norio;Kono Norie;Fujihira Akihiro;Suzuki Kayoko;Yasui-Furukori Norio;Shimoda Kazutaka;Tatsumoto Muneto, Journal of patient safety, 19(1), e9-e10, 09 Jul. 2022

  DOI
• Blood Levels of Ammonia and Carnitine in Patients Treated with Valproic Acid: A Meta-analysis., Yokoyama Saaya;Sugawara Norio;Maruo Kazushi;Yasui-Furukori Norio;Shimoda Kazutaka, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 20(3), 536-547, 31 Aug. 2022

  DOI
• Treatment Discontinuation Among Patients with Schizophrenia Treated with Brexpiprazole and Other Oral Atypical Antipsychotics in Japan: A Retrospective Observational Study., Hishimoto Akitoyo;Yasui-Furukori Norio;Sekine Daisuke;Matsukawa Miyuki;Yamada Sakiko, Advances in therapy, 39(9), 4299-4314, 29 Jul. 2022

  DOI
• HomotopicLI: Rationale, characteristics, and implications of a new threshold-free lateralization index of functional magnetic resonance imaging., Matsuo Kayako;Kono Kenta;Yasui-Furukori Norio;Shimoda Kazutaka;Kaji Yasushi;Akiyama Kazufumi, Laterality, 27(5), 513-543, 10 Aug. 2022

  DOI
• Effect of age and sex on prescriptions for outpatients with bipolar disorder in the MUSUBI study: a cross‑sectional study., Kawamata Yasushi;Yasui-Furukori Norio;Adachi Naoto;Ueda Hitoshi;Hongo Seiji;Azekawa Takaharu;Kubota Yukihisa;Katsumoto Eiichi;Edagawa Koji;Goto Eiichiro;Miki Kazuhira;Kato Masaki;Nakagawa Atsuo;Kikuchi Toshiaki;Tsuboi Takashi;Yoshimura Reiji;Shimoda Kazutaka;Watanabe Koichiro, Annals of general psychiatry, 21(1), 37, 12 Sep. 2022

  DOI
• Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia., Okada Tsuyoshi;Hori Hikaru;Hasegawa Naomi;Murata Atsunobu;Kyou Yoshitaka;Kodaka Fumitoshi;Iida Hitoshi;Ochi Shinichiro;Takaesu Yoshikazu;Tsuboi Takashi;Iga Jun-Ichi;Ichihashi Kayo;Muraoka Hiroyuki;Furihata Ryuji;Yasui-Furukori Norio;Usami Masahide;Onitsuka Toshiaki;Ogasawara Kazuyoshi;Tagata Hiromi;Takeshima Masahiro;Ohi Kazutaka;Numata Shusuke;Hashimoto Naoki;Yamada Hiroki;Makinodan Manabu;Komatsu Hiroshi;Hishimoto Akitoyo;Yamagata Hirotaka;Kido Mikio;Kubota Chika;Atake Kiyokazu;Yamada Hisashi;Nagasawa Tatsuya;Matsumoto Junya;Miura Kenichiro;Inada Ken;Watanabe Koichiro;Suda Shiro;Hashimoto Ryota, Journal of clinical psychopharmacology, 42(6), 591-593, 03 Oct. 2022

  DOI
• Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis., Tsuboi Takashi;Takaesu Yoshikazu;Hasegawa Naomi;Ochi Shinichiro;Fukumoto Kentaro;Ohi Kazutaka;Muraoka Hiroyuki;Okada Tsuyoshi;Kodaka Funitoshi;Igarashi Shun;Iida Hitoshi;Kashiwagi Hiroko;Hori Hikaru;Ichihashi Kayo;Ogasawara Kazuyoshi;Hashimoto Naoki;Iga Jun-Ichi;Nakamura Toshinori;Usami Masahide;Nagasawa Tatsuya;Kido Mikio;Komatsu Hiroshi;Yamagata Hirotaka;Atake Kiyokazu;Furihata Ryuji;Kikuchi Saya;Horai Tadasu;Takeshima Masahiro;Hirano Yoji;Makinodan Manabu;Matsumoto Junya;Miura Kenichiro;Hishimoto Akitoyo;Numata Shusuke;Yamada Hisashi;Yasui-Furukori Norio;Inada Ken;Watanabe Koichiro;Hashimoto Ryota, Psychiatry and clinical neurosciences, 77(1), 30-37, 09 Nov. 2022

  DOI
• Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia"., Inada Ken;Fukumoto Kentaro;Hasegawa Naomi;Yasuda Yuka;Yamada Hisashi;Hori Hikaru;Ichihashi Kayo;Iida Hitoshi;Ohi Kazutaka;Muraoka Hiroyuki;Kodaka Fumitoshi;Ide Kenta;Hashimoto Naoki;Iga Jun-Ichi;Ogasawara Kazuyoshi;Atake Kiyokazu;Takaesu Yoshikazu;Nagasawa Tatsuya;Komatsu Hiroshi;Okada Tsuyoshi;Furihata Ryuji;Kido Mikio;Kikuchi Saya;Kubota Chika;Makinodan Manabu;Ochi Shinichiro;Takeshima Masahiro;Yamagata Hirotaka;Matsumoto Junya;Miura Kenichiro;Usami Masahide;Kishimoto Taishiro;Onitsuka Toshiaki;Katsumoto Eiichi;Hishimoto Akitoyo;Numata Shusuke;Yasui-Furukori Norio;Watanabe Koichiro;Hashimoto Ryota, Neuropsychopharmacology reports, 42(4), 502-509, 18 Oct. 2022

  DOI
• Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders., Fukumoto Kentaro;Kodaka Fumitoshi;Hasegawa Naomi;Muraoka Hiroyuki;Hori Hikaru;Ichihashi Kayo;Yasuda Yuka;Iida Hitoshi;Ohi Kazutaka;Ochi Shinichiro;Ide Kenta;Hashimoto Naoki;Usami Masahide;Nakamura Toshinori;Komatsu Hiroshi;Okada Tsuyoshi;Nagasawa Tatsuya;Furihata Ryuji;Atake Kiyokazu;Kido Mikio;Kikuchi Saya;Yamagata Hirotaka;Kishimoto Taishiro;Makinodan Manabu;Horai Tadasu;Takeshima Masahiro;Kubota Chika;Asami Takeshi;Katsumoto Eiichi;Hishimoto Akitoyo;Onitsuka Toshiaki;Matsumoto Junya;Miura Kenichiro;Yamada Hisashi;Yasui-Furukori Norio;Watanabe Koichiro;Inada Ken;Otsuka Kotaro;Hashimoto Ryota, Neuropsychopharmacology reports, 43(1), 33-39, 16 Nov. 2022

  DOI
• Predictors of psychological distress and sleep deprivation in caregivers of stroke survivors., Sugawara Norio;Yasui-Furukori Norio;Maruo Kazushi;Shimoda Kazutaka;Sumiyoshi Tomiki, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 32(1), 106899, 17 Nov. 2022

  DOI
• Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project., Iida Hitoshi;Okada Tsuyoshi;Nemoto Kiyotaka;Hasegawa Naomi;Numata Shusuke;Ogasawara Kazuyoshi;Miura Kenichiro;Matsumoto Junya;Hori Hikaru;Iga Jun-Ichi;Ichihashi Kayo;Hashimoto Naoki;Yamada Hisashi;Ohi Kazutaka;Yasui-Furukori Norio;Fukumoto Kentaro;Tsuboi Takashi;Usami Masahide;Furihata Ryuji;Takaesu Yoshikazu;Hishimoto Akitoyo;Muraoka Hiroyuki;Katsumoto Eiichi;Nagasawa Tatsuya;Ochi Shinichiro;Komatsu Hiroshi;Kikuchi Saya;Takeshima Masahiro;Onitsuka Toshiaki;Tamai Shinichiro;Kubota Chika;Inada Ken;Watanabe Koichiro;Kawasaki Hiroaki;Hashimoto Ryota, Neuropsychopharmacology reports, 43(1), 23-32, 28 Nov. 2022

  DOI
• The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project., Kyou Yoshitaka;Yasui-Furukori Norio;Hasegawa Naomi;Ide Kenta;Ichihashi Kayo;Hashimoto Naoki;Hori Hikaru;Shimizu Yoshihito;Imamura Yayoi;Muraoka Hiroyuki;Iida Hitoshi;Ohi Kazutaka;Yasuda Yuka;Ogasawara Kazuyoshi;Numata Shusuke;Iga Jun-Ichi;Tsuboi Takashi;Ochi Shinichiro;Kodaka Fumitoshi;Furihata Ryuji;Onitsuka Toshiaki;Makinodan Manabu;Komatsu Hiroshi;Takeshima Masahiro;Kubota Chika;Hishimoto Akitoyo;Atake Kiyokazu;Yamagata Hirotaka;Kido Mikio;Nagasawa Tatsuya;Usami Masahide;Kishimoto Taishiro;Kikuchi Saya;Matsumoto Junya;Miura Kenichiro;Yamada Hisashi;Watanabe Koichiro;Inada Ken;Hahimoto Ryota, Annals of general psychiatry, 21(1), 52, 26 Dec. 2022

  DOI
• A case of musical hallucinations induced by tramadol., Hase Tatsu;Yasui-Furukori Norio;Yamaguchi Shigeki;Shimoda Kazutaka, Neuropsychopharmacology reports, 43(1), 160-162, 19 Jan. 2023

  DOI
• Development and validation of the Japanese version of EPDS-P for indirect screening of paternal perinatal depression based on maternal reporting: Protocol for a prospective longitudinal observational study., Tokumitsu Keita;Yasui-Furukori Norio;Fisher Sheehan David;Keta Takako;Yamada Chihiro;Takeuchi Junko;Yachimori Koji;Sugawara Norio;Shimoda Kazutaka, Neuropsychopharmacology reports, 43(1), 163-170, 25 Jan. 2023

  DOI
• Effect of antipsychotic use by patients with schizophrenia on deceleration capacity and its relation to the corrected QT interval., Okayasu Hiroaki;Shinozaki Takahiro;Takano Yumiko;Sugawara Norio;Fujii Kumiko;Yasui-Furukori Norio;Ozeki Yuji;Shimoda Kazutaka, General hospital psychiatry, 81, 15-21, 14 Jan. 2023

  DOI
• Subjective sleep disturbances across psychiatric illnesses-a transdiagnostic analysis., Nakamura Shuntaro;Sugawara Norio;Kawamata Yasushi;Yasui-Furukori Norio;Shimoda Kazutaka, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 31(2), 229-230, 02 Feb. 2023

  DOI
• The relationship of stress coping styles on substance use, depressive symptoms, and personality traits of nurses in higher education institution., Tokumitsu Keita;Sugawara Norio;Okayasu Hiroaki;Kawamata Yasushi;Shinozaki Masataka;Sato Yoshiteru;Sato Aoi;Uchibori Yumiko;Komatsu Tomie;Yasui-Furukori Norio;Shimoda Kazutaka, Neuropsychopharmacology reports, 05 Mar. 2023

  DOI
• Predictors of psychiatric hospitalization among outpatients with bipolar disorder in the real-world clinical setting., Tokumitsu Keita;Yasui-Furukori Norio;Adachi Naoto;Kubota Yukihisa;Watanabe Yoichiro;Miki Kazuhira;Azekawa Takaharu;Edagawa Koji;Katsumoto Eiichi;Hongo Seiji;Goto Eiichiro;Ueda Hitoshi;Kato Masaki;Nakagawa Atsuo;Kikuchi Toshiaki;Tsuboi Takashi;Watanabe Koichiro;Shimoda Kazutaka;Yoshimura Reiji, Frontiers in psychiatry, 14, 1078045, 16 Mar. 2023

  DOI
• Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years., Yasui-Furukori Norio;Kawamata Yasushi;Sasaki Taro;Yokoyama Saaya;Okayasu Hiroaki;Shinozaki Masataka;Takeuchi Yoshitaka;Sato Aoi;Ishikawa Takaaki;Komahashi-Sasaki Hazuki;Miyazaki Kensuke;Fukasawa Takashi;Furukori Hanako;Sugawara Norio;Shimoda Kazutaka, Neuropsychiatric disease and treatment, 19, 921-928, 17 Apr. 2023

  DOI
• A case of panic attack developing after THC-O acetate inhalation using an e-cigarette device., Sugawara Norio;Yasui-Furukori Norio;Shimoda Kazutaka, Neuropsychopharmacology reports, 04 May 2023

  DOI
• Editorial: Assessing the consequences of antidepressant treatments., Kosel Markus;Ng Chong Guang;Yasui-Furukori Norio, Frontiers in psychiatry, 14, 1185678, 18 Apr. 2023

  DOI
• Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan., Onitsuka Toshiaki;Okada Tsuyoshi;Hasegawa Naomi;Tsuboi Takashi;Iga Jun-Ichi;Yasui-Furukori Norio;Yamada Naoki;Hori Hikaru;Muraoka Hiroyuki;Ohi Kazutaka;Ogasawara Kazuyoshi;Ochi Shinichiro;Takeshima Masahiro;Ichihashi Kayo;Fukumoto Kentaro;Iida Hitoshi;Yamada Hisashi;Furihata Ryuji;Makinodan Manabu;Takaesu Yoshikazu;Numata Shusuke;Komatsu Hiroshi;Hishimoto Akitoyo;Kido Mikio;Atake Kiyokazu;Yamagata Hirotaka;Kikuchi Saya;Hashimoto Naoki;Usami Masahide;Katsumoto Eiichi;Asami Takeshi;Kubota Chika;Matsumoto Junya;Miura Kenichiro;Hirano Yoji;Watanabe Koichiro;Inada Ken;Hashimoto Ryota, Journal of clinical psychopharmacology, 43(4), 365-368, 23 May 2023

  DOI
• Clinical characteristics and prescriptions associated with a 2-year course of rapid cycling and euthymia in bipolar disorder: a multicenter treatment survey for bipolar disorder in psychiatric clinics., Takano Chikashi;Kato Masaki;Adachi Naoto;Kubota Yukihisa;Azekawa Takaharu;Ueda Hitoshi;Edagawa Kouji;Katsumoto Eiichi;Goto Eiichiro;Hongo Seiji;Miki Kazuhira;Tsuboi Takashi;Yasui-Furukori Norio;Nakagawa Atsuo;Kikuchi Toshiaki;Watanabe Koichiro;Kinoshita Toshihiko;Yoshimura Reiji, Frontiers in psychiatry, 14, 1183782, 17 May 2023

  DOI
• Survey of Health Literacy Among Japanese Outpatients with Mental Illness., Sato Yoshiteru;Sugawara Norio;Kawamata Yasushi;Shimoda Kazutaka;Yasui-Furukori Norio, Neuropsychiatric disease and treatment, 19, 1369-1378, 02 Jun. 2023

  DOI
• Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey., Adachi Naoto;Kubota Yukihisa;Goto Eiichiro;Watanabe Koichiro;Yoshimura Reiji;Tsuboi Takashi;Yasui-Furukori Norio;Kato Masaki;Hongo Seiji;Azekawa Takaharu;Katsumoto Eiichi;Edagawa Koji;Nakagawa Atsuo;Kikuchi Toshiaki;Ueda Hitoshi;Miki Kazuhira, Annals of medicine, 55(1), 2224047, Dec. 2023

  DOI
• Item response theory analysis of the University Personality Inventory in medical students., Sugawara Norio;Yasui-Furukori Norio;Sayama Masayuki;Shimoda Kazutaka, Neuropsychopharmacology reports, 27 Jun. 2023

  DOI
• Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project., Hashimoto Naoki;Yasui-Furukori Norio;Hasegawa Naomi;Ishikawa Shuhei;Hori Hikaru;Iida Hitoshi;Ichihashi Kayo;Miura Kenichiro;Matsumoto Junya;Numata Shusuke;Kodaka Fumitoshi;Furihata Ryuji;Ohi Kazutaka;Ogasawara Kazuyoshi;Iga Jun-Ichi;Muraoka Hiroyuki;Komatsu Hiroshi;Takeshima Masahiro;Atake Kiyokazu;Kido Mikio;Nakamura Toshinori;Kishimoto Taishiro;Hishimoto Akitoyo;Onitsuka Toshiaki;Okada Tsuyoshi;Ochi Shinichiro;Nagasawa Tatsuya;Makinodan Manabu;Yamada Hiroki;Tsuboi Takashi;Yamada Hisashi;Inada Ken;Watanabe Koichiro;Hashimoto Ryota, BMC psychiatry, 23(1), 473, 28 Jun. 2023

  DOI
• Relationships between Adherence to Guideline Recommendations for Pharmacological Therapy among Clinicians and Psychotic Symptoms in Patients with Schizophrenia., Kodaka Fumitoshi;Ohi Kazutaka;Yasuda Yuka;Fujimoto Michiko;Yamamori Hidenaga;Hasegawa Naomi;Ito Satsuki;Fukumoto Kentaro;Matsumoto Junya;Miura Kenichiro;Yasui-Furukori Norio;Hashimoto Ryota, The international journal of neuropsychopharmacology, 29 Jun. 2023

  DOI
• Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project., Iida Hitoshi;Okada Tsuyoshi;Nemoto Kiyotaka;Hasegawa Naomi;Numata Shusuke;Ogasawara Kazuyoshi;Miura Kenichiro;Matsumoto Junya;Hori Hikaru;Iga Jun-Ichi;Ichihashi Kayo;Hashimoto Naoki;Yamada Hisashi;Ohi Kazutaka;Yasui-Furukori Norio;Fukumoto Kentaro;Tsuboi Takashi;Usami Masahide;Furihata Ryuji;Takaesu Yoshikazu;Hishimoto Akitoyo;Muraoka Hiroyuki;Katsumoto Eiichi;Nagasawa Tatsuya;Ochi Shinichiro;Komatsu Hiroshi;Kikuchi Saya;Takeshima Masahiro;Onitsuka Toshiaki;Tamai Shinichiro;Kubota Chika;Inada Ken;Watanabe Koichiro;Kawasaki Hiroaki;Hashimoto Ryota, Neuropsychopharmacology reports, 43(1), 23-32, 28 Nov. 2022

  DOI
• Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications., Tokumitsu Keita;Sugawara Norio;Adachi Naoto;Kubota Yukihisa;Watanabe Yoichiro;Miki Kazuhira;Azekawa Takaharu;Edagawa Koji;Katsumoto Eiichi;Hongo Seiji;Goto Eiichiro;Ueda Hitoshi;Kato Masaki;Yoshimura Reiji;Nakagawa Atsuo;Kikuchi Toshiaki;Tsuboi Takashi;Watanabe Koichiro;Yasui-Furukori Norio, Annals of general psychiatry, 22(1), 52, 12 Dec. 2023

  DOI
• Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia., Ito Satsuki;Ohi Kazutaka;Yasuda Yuka;Fujimoto Michiko;Yamamori Hidenaga;Matsumoto Junya;Fukumoto Kentaro;Kodaka Fumitoshi;Hasegawa Naomi;Ishimaru Keiichiro;Miura Kenichiro;Yasui-Furukori Norio;Hashimoto Ryota, Schizophrenia (Heidelberg, Germany), 9(1), 78, 07 Nov. 2023

  DOI
• Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey., Niitsu Tomihisa;Yasui-Furukori Norio;Inada Ken;Kanazawa Tetsufumi;Iyo Masaomi;Ueno Takefumi;Hashimoto Ryota, Schizophrenia research, 27 Oct. 2023

  DOI
• Risk evaluation of diabetic ketoacidosis associated with antipsychotics among patients with schizophrenia in the Japanese adverse event report database., Sugawara Norio;Yasui-Furukori Norio;Shimoda Kazutaka, Journal of psychosomatic research, 175, 111533, 19 Oct. 2023

  DOI
• Differences in self-reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia., Yamada Momoka;Sugawara Norio;Kawamata Yasushi;Yasui-Furukori Norio, Neuropsychopharmacology reports, 43(3), 457-461, 21 Aug. 2023

  DOI
• Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia., Kodaka Fumitoshi;Ohi Kazutaka;Yasuda Yuka;Fujimoto Michiko;Yamamori Hidenaga;Hasegawa Naomi;Ito Satsuki;Fukumoto Kentaro;Matsumoto Junya;Miura Kenichiro;Yasui-Furukori Norio;Hashimoto Ryota, The international journal of neuropsychopharmacology, 26(8), 557-565, 29 Aug. 2023

  DOI
• Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study., Hasegawa Naomi;Yasuda Yuka;Yasui-Furukori Norio;Yamada Hisashi;Hori Hikaru;Ichihashi Kayo;Takaesu Yoshikazu;Iida Hitoshi;Muraoka Hiroyuki;Kodaka Fumitoshi;Iga Jun-Ichi;Hashimoto Naoki;Ogasawara Kazuyoshi;Ohi Kazutaka;Fukumoto Kentaro;Numata Shusuke;Tsuboi Takashi;Usami Masahide;Hishimoto Akitoyo;Furihata Ryuji;Kishimoto Taishiro;Nakamura Toshinori;Katsumoto Eiichi;Ochi Shinichiro;Nagasawa Tatsuya;Atake Kiyokazu;Kubota Chika;Komatsu Hiroshi;Yamagata Hirotaka;Ide Kenta;Takeshima Masahiro;Kido Mikio;Kikuchi Saya;Okada Tsuyoshi;Matsumoto Junya;Miura Kenichiro;Shimazu Taichi;Inada Ken;Watanabe Koichiro;Hashimoto Ryota, Psychiatry and clinical neurosciences, 77(10), 559-568, 08 Sep. 2023

  DOI
• Relationship Between Diabetic Chorea and Timing of MRI Findings: A Systematic Review with Case Reports., Otaka Yumi;Harada Yukinori;Sugawara Norio;Shimizu Taro;Yasui-Furukori Norio, International journal of general medicine, 16, 4465-4476, 02 Oct. 2023

  DOI
• Factors associated with the initiation of laxative use in the same patients with schizophrenia over a 20-year period: Retrospective cohort study., Kawamata Yasushi;Sugawara Norio;Sasaki Taro;Yokoyama Saaya;Okayasu Hiroaki;Shinozaki Masataka;Takeuchi Yoshitaka;Sato Aoi;Ishikawa Takaaki;Komahashi-Sasaki Hazuki;Miyazaki Kensuke;Fukasawa Takashi;Furukori Hanako;Yasui-Furukori Norio, Neuropsychopharmacology reports, 44(1), 60-66, 12 Sep. 2023

  DOI
• Enhancing functionality of psychiatric department in general hospital without psychiatric ward: Role of full-time psychiatrist., Funayama Michitaka;Taira Toshihiro;Saeki Yoshinori;Kato On;Suda Shiro;Yasui-Furukori Norio;Anamizu Sachiko;Sato Koichi;Muroi Hideta;Satake Naoko;Koishikawa Hiraki;Sato Shigeki;Nishimura Katsuji, Asian journal of psychiatry, 89, 103751, 19 Aug. 2023

  DOI
• Effects of age on suicide attempts by medication in patients transferred to the emergency rooms of two advanced medical centers: A retrospective chart review of the DJ project., Sasaki Taro;Shinozaki Masataka;Nemoto Aki;Nagao Yukiko;Yasuda Manabu;Shimoda Kazutaka;Suda Shiro;Yasui-Furukori Norio, Neuropsychopharmacology reports, 43(3), 453-456, 11 Jul. 2023

  DOI
• Predictors of somatic symptoms during the COVID-19 pandemic: a national longitudinal survey in Japan., Sugawara Norio;Tabuchi Takahiro;Tokumitsu Keita;Yasui-Furukori Norio, BMJ open, 14(5), e082439, 07 May 2024

  DOI
• Continuous alcohol withdrawal delirium and physical illness-associated delirium in a man brought to the emergency department after a disaster: A case report., Kikuchi Kota;Hasegawa Chie;Sasaki Taro;Sato Yoshiteru;Owada Tamaki;Shindo Yunosuke;Kawamata Yasushi;Sugawara Norio;Yasui-Furukori Norio, Neuropsychopharmacology reports, 25 Apr. 2024

  DOI
• Vortioxetine-induced syndrome of inappropriate secretion of antidiuretic hormone: A case report., Sasaki Taro;Shindo Yunosuke;Kikuchi Kota;Kawamata Yasushi;Sugawara Norio;Yasui-Furukori Norio, Neuropsychopharmacology reports, 08 Apr. 2024

  DOI
• Changes in suicidal ideation during treatment among patients with major depressive disorder: A 6-month naturalistic follow-up study., Sato Aoi;Sugawara Norio;Kawamata Yasushi;Yasui-Furukori Norio, Neuropsychopharmacology reports, 05 Mar. 2024

  DOI